Split (1)

train · 500 rows

patient_id string	sex string	race_ethnicity string	geographic_region string	residence_type string	socioeconomic_status string	primary_language string	insurance_type string	primary_disease_category string	disease_class string	orpha_code int64	omim_number int64	inheritance_pattern string	disease_severity_index float64	expected_mortality_by18_untreated float64	age_at_symptom_onset_yrs float64	age_at_diagnosis_yrs float64	diagnostic_delay_years float64	prior_misdiagnoses_count int64	specialists_seen_count int64	pcp_visits_count int64	er_visits_pre_diagnosis int64	hospitalization_pre_diagnosis int64	newborn_screening_eligible int64	newborn_screening_caught int64	newborn_screening_age_at_flag_days float64	genetic_test_modality string	time_to_genetic_test_months float64	genetic_test_insurance_denial_flag int64	genetic_test_cost_usd int64	pathogenic_variant_confirmed int64	diagnosis_source string	diagnostic_odyssey_cost_usd float64	parent_self_advocacy_score float64	developmental_milestones_status string	gross_motor_quotient float64	fine_motor_quotient float64	expressive_language_quotient float64	receptive_language_quotient float64	cognitive_quotient float64	autism_spectrum_comorbid_flag int64	adhd_comorbid_flag int64	seizure_flag int64	seizure_onset_age_yrs float64	seizure_medications_count int64	cardiac_involvement_flag int64	lvh_severity string	respiratory_involvement_flag int64	fvc_pct_predicted float64	niv_use_flag int64	tracheostomy_flag int64	gi_involvement_flag int64	g_tube_flag int64	hepatic_involvement_flag int64	renal_involvement_flag int64	ophthalmologic_involvement_flag int64	hearing_loss_flag int64	skeletal_involvement_flag int64	short_stature_zscore float64	bmi_zscore float64	plasma_amino_acids_abnormal int64	urine_organic_acids_abnormal int64	acylcarnitine_profile_abnormal int64	urine_gag_elevated int64	chitotriosidase_u_l float64	lyso_gb1_ng_ml float64	lyso_gb3_ng_ml float64	gaa_activity_nmol_hr_mg float64	gla_activity_nmol_hr_mg float64	ammonia_umol_l float64	lactate_mmol_l float64	pyruvate_mmol_l float64	ck_u_l float64	ldh_u_l float64	ast_u_l float64	ferritin_ng_ml float64	soluble_il2r_u_ml float64	orphan_drug_available_for_condition int64	treatment_received string	ert_product string	gene_therapy_product string	aso_product string	small_molecule_product string	treatment_start_age_yrs float64	treatment_delay_from_dx_months float64	treatment_cost_annual_usd float64	payer_coverage_status string	appeal_submitted_flag int64	appeal_success_flag int64	time_to_treatment_access_months float64	patient_assistance_program_enrolled_flag int64	copay_out_of_pocket_annual_usd float64	icer_value_assessment string	qaly_estimate_per_year float64	treatment_adherence_pct float64	infusion_reaction_flag int64	treatment_efficacy_response string	hsct_performed_flag int64	hsct_donor_type string	hsct_gvhd_flag int64	hsct_engraftment_success_flag int64	disease_progression_velocity string	hospitalization_annual_count int64	hospitalization_days_annual int64	metabolic_crisis_count int64	icu_admission_flag int64	respiratory_failure_event_flag int64	ambulation_status_age18 string	communication_status_age18 string	g_tube_dependent_age18 int64	ventilator_dependent_age18 int64	school_placement string	iep_504_plan_flag int64	therapies_received_count int64	mortality_flag int64	age_at_death_yrs float64	cause_of_death string	hospice_palliative_care_flag int64	caregiver_zarit_score float64	caregiver_phq9_score float64	caregiver_gad7_score float64	caregiver_employment_disruption_flag int64	caregiver_lost_income_annual_usd float64	caregiver_sleep_hours_per_night float64	household_out_of_pocket_annual_usd float64	ped_qol_total float64	ped_qol_physical float64	ped_qol_emotional float64	ped_qol_social float64	ped_qol_school float64	sibling_impact_score float64	marital_strain_flag int64	divorce_separation_flag int64	parent_advocacy_group_member_flag int64	social_media_rare_community_engagement_flag int64	clinical_trial_participation_flag int64	natural_history_study_enrollment_flag int64	patient_registry_enrollment_flag int64	distance_to_specialty_center_miles float64	travel_burden_days_per_year int64	telehealth_use_flag int64	language_barrier_interpretation_needed_flag int64	immigration_status_concern_flag int64	food_insecurity_flag int64	housing_instability_flag int64	transportation_barrier_flag int64	missed_appointments_annual_count int64	sdoh_composite_risk_score float64
HCG5-0000000	Female	White_non_Hispanic	Europe	Suburban	Low	Mandarin	Medicaid_CHIP	Achondroplasia	SKEL	15	100,800	AD	4.62	0.04	0.029	2.357	2.328	2	7	9	2	1	0	0	null	Panel	3.12	0	1,500	1	Geneticist	34,545.53	4.62	Delayed	58.3	63.9	59.8	78.4	78.7	1	0	0	1.43	3	0	null	0	114.8	1	0	1	0	0	0	0	0	1	1.05	1.85	0	0	0	0	623.65	36.085	4.513	3.95	16.17	166.3	2.43	0.208	569.2	243.7	78.7	392.3	328	0	Small_molecule	null	null	null	Supportive_metabolic	2.55	20.81	118,263	Fully_covered	0	0	2.86	0	15,419	Intermediate	0.233	0.717	0	Partial	0	null	0	0	Slow_progression	2	18	1	1	0	Assisted	Limited_verbal	0	0	Home_school_medical	1	2	0	null	null	0	27.8	21.1	6.7	1	34,472	6.6	36,091	54.1	60.5	77	77.1	77.9	61.1	0	0	1	1	1	0	0	27.3	3	0	1	0	0	0	0	1	2.12
HCG5-0000001	Female	White_non_Hispanic	MENA	Urban	Middle	English	Commercial	ASS1_citrullinemia	UCD	247,525	215,700	AR	6.2	0.4	0.01	0.1	0.054	0	4	19	1	0	0	0	null	Karyotype	19.62	1	1,200	0	Geneticist	17,265.48	6.48	Regression	49	82.1	85.2	39.9	96.5	0	0	0	2.56	1	0	null	1	32.8	0	0	0	0	1	0	0	0	0	-2.12	-0.95	1	0	0	1	52.95	42.906	20.926	3.62	3.57	20.3	1.6	0.046	366.1	466.8	215.9	282	383.2	1	Supportive_only	null	null	null	null	null	72	0	Partial_coverage	0	0	3.71	0	5,738	Intermediate	0.455	null	0	Not_applicable	0	null	0	0	Moderate	4	8	4	1	0	Wheelchair	AAC_device	0	0	Special_ed	1	1	1	3.63	Metabolic_crisis	1	35.4	16.2	18.7	1	25,266	5.8	20,586	51.3	22.1	84.4	35.1	47.9	51.7	0	0	1	0	0	0	1	55.2	10	1	0	0	0	0	1	5	3.02
HCG5-0000002	Male	White_non_Hispanic	North_America	Rural	High	English	Medicaid	XLP	IMM	538	308,240	XLR	8.03	0.5	5.705	18	15	3	7	16	1	1	0	0	null	WES	15.82	0	4,500	1	Geneticist	18,463	6.15	Profound_delay	81.3	48.9	40.6	34.8	22.1	0	1	0	6.89	3	0	null	0	87.8	0	0	0	0	1	0	0	0	1	1.23	0.3	0	0	0	0	248.09	37.991	10.644	6.95	12.35	20	6	0.119	294.4	729.5	29.3	32.4	837.6	0	Supportive_only	null	null	null	null	null	1.74	0	Fully_covered	0	0	0.95	0	1,275	Intermediate	0.156	null	0	Not_applicable	0	null	0	0	Stable	0	44	0	0	0	Bedbound	Nonverbal	0	0	Home_school_medical	1	6	0	null	null	0	45.4	10	13.5	1	111,013	7.5	3,027	51.5	51.4	60	50.6	46.5	52.2	0	0	1	1	0	0	1	234.1	33	1	0	0	0	0	0	2	0.71
HCG5-0000003	Male	White_non_Hispanic	Europe	Suburban	High	Spanish	Commercial	X_ALD	LD	43	300,100	XLR	6.53	0.55	0.011	0.011	0	0	3	11	0	1	1	1	4.1	WES	1.22	0	4,500	0	NBS_followup	9,684.75	6.54	Regression	106.1	54	43.1	57.5	32	0	0	0	6.98	5	0	null	1	19.1	1	0	0	0	0	0	1	0	0	-2.79	-3.83	0	0	0	0	244.45	20.652	17.414	2.43	3.38	34.9	1.71	0.177	120.2	160.7	128.6	751.6	1,407.4	1	Small_molecule	null	null	null	Supportive_metabolic	0.13	17.39	1,439,134	Prior_auth_required	0	0	4.03	0	18,054	Low_value	0.397	0.686	0	Responder	0	null	0	0	Stable	1	22	0	0	0	Wheelchair	AAC_device	0	0	Not_enrolled	0	1	0	null	null	1	16.2	13.8	14.4	0	0	7.5	6,724	68.6	48.3	91.9	49	42.2	75.7	0	0	0	0	0	0	0	714.2	16	1	0	1	0	1	0	0	4.72
HCG5-0000004	Male	Black_non_Hispanic	Asia_Pacific	Urban	Low	English	Commercial	Fabry	LSD	324	301,500	XLR	4.66	0.04	4.073	16.818	12.745	2	11	8	2	0	0	0	null	Panel	11.19	0	1,500	1	Cardiologist	10,826.28	7.12	Delayed	90.4	78.5	91	80	94	0	1	1	1.7	8	1	Mild	0	89.4	0	0	1	0	0	1	1	1	1	-2.58	-2.93	0	0	1	0	339.59	28.315	29.939	6.2	2.12	40	3.47	0.185	399.9	595.6	20.8	1,242.1	796.5	1	Gene_therapy	null	Clinical_trial	null	null	18	7.06	1,141,560	Prior_auth_required	0	0	2.6	1	1,509	Cost_saving	0.224	0.709	0	Responder	0	null	0	0	Slow_progression	2	21	2	0	1	Assisted	Limited_verbal	1	0	Special_ed	1	5	0	null	null	0	48.8	11.6	9.5	1	12,150	4.5	2,200	18.6	42.6	68	85.5	51	34.7	0	1	1	1	0	1	1	370.3	6	0	0	0	0	0	0	0	1.03
HCG5-0000005	Female	White_non_Hispanic	Europe	Rural	Low	Spanish	Commercial	22q11_2_DiGeorge	SYN	567	188,400	AD	4.35	0.08	0.01	4.071	4.061	2	9	7	0	1	0	0	null	Panel	13.9	0	1,500	0	Geneticist	31,144.82	5.61	Delayed	99.8	107.8	61.1	77.1	74.5	0	0	1	6.55	4	1	Mild	0	114	0	0	0	0	1	0	0	1	0	-2.64	0.4	1	0	0	0	234.06	52.688	2.797	7.06	22.67	48.1	2.18	0.219	20	142.6	102.1	32	2,085.4	0	Supportive_only	null	null	null	null	null	16.31	0	Fully_covered	0	0	5.77	0	394	Intermediate	0.383	null	0	Not_applicable	0	null	0	0	Rapid	11	30	1	0	0	Assisted	Limited_verbal	1	0	Special_ed	1	1	0	null	null	0	46.7	18.9	0.1	1	64,656	5.7	11,638	36.3	61.2	73.9	49.1	42.6	66.7	1	0	0	0	0	1	1	18.5	9	1	0	0	0	0	0	16	0.3
HCG5-0000006	Male	Asian	Asia_Pacific	Urban	High	English	Medicaid_CHIP	OI_type1_to_4	SKEL	666	166,200	AD	7.32	0.06	0.01	2.341	2.331	1	22	14	0	0	0	0	null	MLPA	15.11	0	1,000	1	Geneticist	21,158.76	5.71	Regression	84.3	56	36.6	34.8	83.3	0	1	1	1.86	5	0	null	1	81.7	0	0	0	0	0	0	0	0	1	-3.34	0.64	0	0	0	0	181.76	8.293	9.337	5.9	2.38	28.3	2.14	0.307	355.8	734.2	28.9	744.9	329.9	1	Supportive_only	null	null	null	null	null	5.05	0	Denied	0	0	30.82	0	396	Intermediate	0.465	null	0	Not_applicable	0	null	0	0	Stable	5	41	2	0	1	Wheelchair	AAC_device	1	0	Not_enrolled	1	6	1	11.73	Cardiac	1	44.3	15.5	15	0	0	7.3	17,637	70.2	26.5	62.2	29.9	46.5	46.4	0	0	1	0	0	1	0	76.3	9	0	0	0	0	0	0	1	0.33
HCG5-0000007	Female	White_non_Hispanic	Europe	Urban	High	English	Commercial	Hypophosphatasia	SKEL	436	241,500	AR	7.48	0.25	0.605	1.79	1.185	3	9	13	2	1	0	0	null	Panel	33.74	0	1,500	0	Metabolic_specialist	254,450.84	6.62	Regression	91.2	48.5	24	57.4	38.8	0	1	1	2.69	4	0	null	1	78	0	0	1	0	0	0	0	0	1	-3.83	-1.02	0	0	0	0	278.27	22.226	8.194	1.88	2.65	20	3.33	0.209	21.7	324	27.7	1,558.4	1,458.2	1	SRT	null	null	null	null	4.79	0.65	1,152,729	Prior_auth_required	0	0	1.59	0	7,328	Low_value	0.473	0.554	0	Partial	0	null	0	0	Slow_progression	1	29	1	0	0	Wheelchair	AAC_device	1	0	Home_school_medical	0	6	0	null	null	0	48.5	16.7	10.3	0	0	4.9	39,325	60.1	36.5	53	51.1	40.3	91.4	1	0	1	1	0	1	0	144.2	13	1	0	0	0	0	1	2	2.45
HCG5-0000008	Male	Hispanic	North_America	Urban	Middle	English	Commercial	Pompe_infantile	LSD	365	232,300	AR	10	0.85	0.023	0.023	0	0	4	7	1	0	1	1	8.5	WGS	1.78	0	8,500	1	NBS_followup	45,927.9	3	Profound_delay	29.6	74.9	12.8	23.4	43.1	1	0	0	4.81	4	1	Severe	1	53.3	1	0	1	1	1	0	1	1	1	-2.07	-1.37	1	1	0	0	417.67	1.616	7.569	3.98	5.03	26	5.62	0.072	356.1	255.4	36.6	33.9	1,475.2	1	SRT	null	null	null	null	0.83	4.35	84,184	Prior_auth_required	0	0	16.65	0	2,354	Low_value	0.157	0.683	0	Responder	0	null	0	0	Stable	1	18	1	1	0	Bedbound	Nonverbal	1	0	Special_ed	0	0	1	10.15	Infection	1	46.8	13.8	13.6	1	56,894	7	23,808	37.1	26.7	61.2	27.1	75.6	57.8	1	0	1	1	1	0	0	88.3	2	0	0	0	0	0	1	6	0.68
HCG5-0000009	Male	White_non_Hispanic	Asia_Pacific	Suburban	Middle	Spanish	Medicaid	ARG1	UCD	90	207,800	AR	9.97	0.25	1.523	9.675	8.152	0	7	15	0	1	0	0	null	Single_gene	9.23	0	800	1	Cardiologist	9,542.15	4.1	Profound_delay	19.4	63.4	14.8	55.1	57.3	1	0	0	2.96	1	0	null	0	112.5	0	0	0	1	1	0	0	0	0	-1.63	-0.97	1	0	0	0	1,092.75	43.216	4.458	2.94	2.56	433.2	2.67	0.179	80	435.8	26	146.4	425	1	Supportive_only	null	null	null	null	null	14.61	0	Prior_auth_required	0	0	29.99	0	297	Low_value	0.304	null	0	Not_applicable	0	null	0	0	Slow_progression	8	21	2	0	0	Bedbound	Nonverbal	1	1	Mainstream	1	0	1	12.65	Respiratory_failure	1	34.2	0	11.1	1	26,116	2.8	9,253	46.3	9.2	57.9	67.3	34.6	24.4	1	0	1	0	0	0	1	41	28	0	1	0	0	0	0	1	0
HCG5-0000010	Male	Black_non_Hispanic	North_America	Urban	Middle	English	Uninsured	MSUD	OA	511	248,600	AR	8.06	0.55	0.014	0.014	0	0	1	10	2	0	1	1	5.1	Single_gene	0.48	0	800	1	NBS_followup	6,754.25	5.2	Profound_delay	80.6	72.6	56.6	48.7	57.9	0	0	0	2.05	0	0	null	0	97.5	0	0	0	1	1	0	0	0	1	-2.66	-0.09	1	1	0	0	60.19	10.975	6.33	4.22	6.69	34.5	1.66	0.269	1,199.9	225.6	60.2	96.1	2,271.9	0	Supportive_only	null	null	null	null	null	44	0	Fully_covered	0	0	15.93	0	318	Low_value	0.064	null	0	Not_applicable	0	null	0	0	Slow_progression	9	24	3	0	0	Bedbound	Nonverbal	1	1	Mainstream_with_support	1	6	1	7.68	Metabolic_crisis	0	39.5	21.3	0	1	89,606	5.7	8,551	60.6	33.6	65.6	50.3	23.4	45.7	0	0	1	1	1	0	1	59.5	23	1	0	0	0	0	0	8	0
HCG5-0000011	Female	Black_non_Hispanic	North_America	Urban	Middle	Other	Commercial	CDKL5_encephalopathy	SYN	3,095	300,672	XLD	10	0.22	0.419	13.883	13.464	2	9	15	5	0	0	0	null	Panel	6.87	0	1,500	1	Immunologist	38,497.72	4.15	Profound_delay	17.6	28.5	10	20.6	10	1	0	0	7.59	3	0	null	1	45.3	1	0	1	1	0	0	1	0	0	-2.37	-4.1	0	1	0	0	28.82	11.241	4.533	2.63	4.96	91.3	5.41	0.173	288.2	472.5	105.5	714.3	206.6	0	Small_molecule	null	null	null	Supportive_metabolic	17.54	15.58	327,668	Prior_auth_required	0	0	9.1	0	2,702	High_value	0.532	0.702	0	Partial	0	null	0	0	Stable	0	45	1	0	0	Bedbound	Nonverbal	1	0	Home_school_medical	1	3	0	null	null	0	39.1	13.6	9.3	1	18,320	5.1	4,692	73	3.1	10.5	24.2	1.4	32.9	0	1	1	1	0	0	1	67.9	10	1	1	0	0	0	0	0	2.7
HCG5-0000012	Male	White_non_Hispanic	Europe	Urban	Low	Spanish	Other_public	Congenital_myopathy	NM	97,245	160,150	AR	5.66	0.18	0.694	12.418	11.724	12	14	14	1	1	0	0	null	MLPA	14.31	1	1,000	1	Geneticist	18,822.71	4.86	Delayed	44.7	53.5	21.4	76.3	129.3	1	0	0	2.93	0	0	null	1	63.4	0	0	0	0	0	0	0	0	0	-0.06	0.34	0	1	0	0	38.59	19.891	25.596	12.12	5.14	20	2.99	0.179	259.5	343.1	10.2	155.1	911.2	0	Small_molecule	null	null	null	Supportive_metabolic	12.81	50.4	227,601	Fully_covered	0	0	21.81	1	821	Low_value	0.457	0.574	0	Responder	0	null	0	0	Stable	5	20	2	0	0	Assisted	Limited_verbal	0	0	Mainstream	0	4	0	null	null	0	55.3	18.5	6.3	0	0	7.1	37,186	48.3	36.3	45.3	42.8	72.3	83.9	0	1	0	1	1	0	0	22.7	7	1	1	0	0	1	1	14	5.47
HCG5-0000013	Male	Native_American	Asia_Pacific	Urban	Low	Spanish	Other_public	SCID	IMM	183	300,400	XLR	10	0.92	0.02	0.02	0	0	4	12	0	0	1	1	7.3	Panel	0.54	0	1,500	1	NBS_followup	89,172.45	5.68	Profound_delay	16.9	10	36.4	42.3	46.7	1	0	0	4.91	1	0	null	0	107.5	0	0	0	1	0	0	0	0	0	-0.63	-0.35	1	0	0	0	29.57	38.752	17.11	5.2	1.91	24.3	2.47	0.136	421.4	100	39.6	148.4	3,973.8	1	Supportive_only	null	null	null	null	null	5.8	0	Denied	0	0	11.82	0	2,063	Intermediate	0.209	null	0	Not_applicable	1	MSD	1	1	Slow_progression	5	8	1	0	0	Bedbound	Nonverbal	1	0	Home_school_medical	1	2	1	5.22	Respiratory_failure	1	35.1	12	12.5	0	0	5.4	2,530	68.7	0	43.2	38.5	71.1	41.8	1	0	1	1	0	0	0	60.2	7	1	1	0	1	0	0	4	3.73
HCG5-0000014	Male	White_non_Hispanic	Latin_America	Urban	Low	English	Uninsured	ARG1	UCD	90	207,800	AR	5.53	0.25	0.848	3.072	2.224	2	10	6	1	0	0	0	null	WES	28.39	0	4,500	1	NBS_followup	34,671.64	8.2	Delayed	61.7	84	48	55	38.4	0	0	0	2.87	3	1	Mild	1	25.8	0	1	0	0	1	0	0	0	1	-2.11	-0	1	1	1	0	54.62	191.072	16.075	1.23	0.74	20	4.12	0.242	91.8	243.4	20.9	388.9	195.4	1	Supportive_only	null	null	null	null	null	5.3	0	Partial_coverage	0	0	18.17	0	4,312	High_value	0.673	null	0	Not_applicable	0	null	0	0	Stable	9	32	2	0	1	Assisted	Limited_verbal	0	0	Special_ed	0	0	1	9.86	Cardiac	1	38.7	22.4	12.7	0	0	6.8	2,126	66.4	27.4	33.7	51.3	24.7	69.6	0	0	1	1	0	0	1	11.6	12	1	0	0	0	0	0	3	0.16
HCG5-0000015	Male	White_non_Hispanic	North_America	Urban	High	Spanish	Commercial	MPS_III_Sanfilippo	LSD	581	252,900	AR	8.48	0.7	3.166	7.015	3.849	1	16	13	0	1	0	0	null	Panel	16.95	0	1,500	0	NBS_followup	4,517.58	7.75	Profound_delay	10	48.9	40.3	58.8	57.7	0	0	1	2.9	3	1	Mild	0	64.7	0	0	0	1	1	0	1	0	1	-1.28	-0.6	1	0	0	1	48.11	5.486	2.151	1.55	1.57	223.9	2.7	0.144	995.3	401.6	84.2	1,360.5	3,536.9	0	Supportive_only	null	null	null	null	null	14.55	0	Partial_coverage	0	0	7.44	0	3,163	Intermediate	0.504	null	0	Not_applicable	0	null	0	0	Rapid	2	6	0	1	0	Bedbound	Nonverbal	1	0	Home_school_medical	1	2	1	18	Respiratory_failure	1	49.2	10.3	21	1	6,308	6.4	2,004	32.2	20.6	38.4	18.2	56.6	67.2	1	0	1	0	0	0	0	624.7	13	0	0	0	0	0	0	5	1.42
HCG5-0000016	Male	Hispanic	North_America	Urban	Low	Other	Commercial	SMA_type1	NM	83,330	253,300	AR	10	0.9	0.252	2.008	1.756	3	11	6	1	0	1	0	null	WES	34.59	0	4,500	1	Other	10,748.46	6.51	Profound_delay	10	10	56.9	47	51.4	0	0	0	2.33	2	0	null	1	51.8	0	1	1	1	0	0	0	0	0	-3.76	-2.61	0	0	0	0	119.54	10.334	70.384	11.75	1.7	20	9.72	0.21	595.3	622.2	120.8	228.6	563.4	1	Supportive_only	null	null	null	null	null	6.6	0	Fully_covered	0	0	2.57	0	30,000	Intermediate	0.401	null	0	Not_applicable	0	null	0	0	Rapid	0	10	1	0	0	Bedbound	Nonverbal	1	0	Mainstream_with_support	0	5	1	13.34	Metabolic_crisis	1	28.7	13.6	13.8	0	0	4.9	17,582	34.1	42.8	66.5	24.4	50.9	34.5	0	1	1	1	0	1	0	31.1	21	1	1	0	0	0	0	2	2.66
HCG5-0000017	Female	Hispanic	MENA	Urban	Low	English	Medicaid	Gaucher_type2_3	LSD	77,259	230,900	AR	8.83	0.72	1.511	5.205	3.695	0	11	12	0	1	0	0	null	WES	5.82	0	4,500	1	Metabolic_specialist	14,650.74	7.06	Profound_delay	31.4	68.1	39.7	65.4	70.6	1	0	0	2.81	8	0	null	0	61.1	0	0	1	1	1	0	1	0	1	-1.48	-2.16	0	0	0	0	426.29	27.271	8.434	3.88	4.32	61.6	2.23	0.196	133.7	430.8	39.6	145.8	1,001.8	1	Chaperone	null	null	null	null	6.09	34.29	1,318,812	Fully_covered	0	0	19.06	0	4,794	Intermediate	0.335	0.605	0	Responder	0	null	0	0	Moderate	0	33	1	0	0	Bedbound	Nonverbal	1	1	Mainstream_with_support	0	1	1	10.98	Metabolic_crisis	1	42.7	13.7	8.4	1	91,906	6.9	15,724	69.7	18.8	61.4	55.6	42.5	27.9	0	0	1	1	0	1	1	87.1	17	1	0	0	1	0	0	3	2.2
HCG5-0000018	Male	White_non_Hispanic	North_America	Suburban	Middle	English	Commercial	WAS_Wiskott	IMM	906	301,000	XLR	5.97	0.55	0.816	3.197	2.381	2	18	6	0	0	0	0	null	WES	4.8	0	4,500	0	Geneticist	40,047.97	6.54	Delayed	39.6	56.6	89.9	74.7	85.8	1	0	1	0.81	5	0	null	1	27.8	1	0	0	0	1	0	1	0	1	-1.87	2.04	0	0	1	0	339.16	11.541	58.567	3.28	1.59	59	4.44	0.169	72.7	617.2	27.3	179	7,380.2	1	Gene_therapy	null	Clinical_trial	null	null	3.25	2.13	363,264	Fully_covered	0	0	36	0	28,950	Intermediate	0.305	0.769	0	Partial	1	MUD	0	1	Stable	4	19	0	0	1	Assisted	Limited_verbal	1	0	Not_enrolled	1	2	1	11.07	Infection	0	47.1	3.7	8.4	1	38,471	6.5	9,366	80.5	21.5	79.6	82.1	24.8	65.7	0	0	1	0	0	0	1	61.8	13	1	0	0	0	0	0	4	0.41
HCG5-0000019	Female	White_non_Hispanic	North_America	Urban	Low	English	Commercial	CMT_1A_1B	NM	101,081	118,220	AD	2.96	0.02	2.313	4.514	2.201	1	3	16	0	1	0	0	null	Panel	34.33	1	1,500	1	Metabolic_specialist	10,430.85	7.44	On_track	99.9	77.6	77.9	76.7	78.1	0	0	0	1.33	4	0	null	1	45.7	0	0	0	0	0	0	0	0	0	-2.25	-1.43	0	0	0	0	97.3	47.103	23.908	11.05	0.89	53.9	2.9	0.201	156.3	233.5	14.4	504.7	965.9	0	Small_molecule	null	null	null	Supportive_metabolic	9.07	25.76	4,663,862	Fully_covered	0	0	4.92	0	3,489	Intermediate	0.278	0.834	0	Partial	0	null	0	0	Slow_progression	0	6	2	1	1	Ambulatory	Verbal	0	0	Special_ed	1	5	0	null	null	0	46.5	14.4	12.3	1	48,850	4	8,209	61.7	47.9	84.4	52.8	68	42	0	0	1	0	0	1	1	55.5	30	0	1	0	0	0	0	7	4.24
HCG5-0000020	Female	Asian	North_America	Suburban	Low	English	Commercial	OI_type1_to_4	SKEL	666	166,200	AD	6.23	0.06	0.01	2.103	2.093	0	4	5	0	0	0	0	null	Panel	12.55	0	1,500	1	Cardiologist	30,869.87	3.15	Regression	59.6	32.6	77.5	27.4	26	1	0	0	2.61	0	0	null	0	109.8	0	0	1	0	0	0	0	1	0	-1.76	0.89	0	0	0	0	106.07	19.087	9.89	3.97	1.18	20	2.9	0.179	215	525.2	174.9	56.6	9,079.4	1	Supportive_only	null	null	null	null	null	37.67	0	Fully_covered	0	0	6.82	0	548	Intermediate	0.631	null	0	Not_applicable	0	null	0	0	Slow_progression	4	10	0	0	0	Wheelchair	AAC_device	0	0	Special_ed	1	3	0	null	null	0	51.7	17.8	14.8	1	20,193	6.4	1,839	74.2	83.7	79.3	57.8	77.7	50.3	0	0	1	1	0	1	0	95	29	1	0	0	1	0	0	7	1.01
HCG5-0000021	Male	Hispanic	Europe	Urban	Middle	Spanish	Commercial	MSUD	OA	511	248,600	AR	7.56	0.55	0.012	0.012	0	0	3	13	2	0	1	1	4.2	Karyotype	0.9	0	1,200	1	NBS_followup	8,082.57	3.99	Regression	61.3	62.5	35.6	54.4	66.3	0	1	1	3.12	1	0	null	0	109.4	0	0	0	1	0	0	0	0	0	-1.95	-2.13	1	1	0	0	1,353.94	49.244	76.622	1.72	4.71	20	1.79	0.276	66.6	529.6	112.5	240.3	1,332.4	0	Supportive_only	null	null	null	null	null	14.9	0	Fully_covered	0	0	7.39	0	956	Intermediate	0.469	null	0	Not_applicable	0	null	0	0	Slow_progression	6	29	2	0	0	Wheelchair	AAC_device	0	0	Home_school_medical	1	2	0	null	null	0	37.2	15.8	4.7	1	85,811	5.2	7,875	57.5	8.6	58.7	99.7	76.3	53.8	0	0	0	1	0	1	1	167.5	17	1	1	0	0	0	1	1	5.39
HCG5-0000022	Male	Other_Multi	Latin_America	Urban	Middle	English	Medicaid	22q11_2_DiGeorge	SYN	567	188,400	AD	3.32	0.08	0.01	1.894	1.884	2	22	18	2	1	0	0	null	WES	22.17	0	4,500	1	Metabolic_specialist	27,053.37	8.64	Delayed	86.8	88.9	79	84.9	44.6	1	0	0	2.23	6	1	Moderate	0	95.1	0	0	1	0	0	0	1	0	1	-3.38	-0.42	0	0	0	0	328.58	17.75	20.3	1.82	6.16	43.1	1.8	0.217	141.4	161.5	11.2	87.2	1,661.4	0	Supportive_only	null	null	null	null	null	27.22	0	Denied	0	0	1.78	0	1,021	Intermediate	0.231	null	0	Not_applicable	0	null	0	0	Moderate	1	9	0	0	0	Ambulatory	Verbal	1	0	Special_ed	1	4	0	null	null	0	29.2	25.9	8.6	1	44,232	6.4	20,602	60.5	68.5	92	67.1	67.4	1	1	0	1	1	0	1	1	54.7	7	0	0	0	0	0	1	1	2.02
HCG5-0000023	Female	Black_non_Hispanic	Asia_Pacific	Urban	Middle	English	Medicaid_CHIP	Lamellar_ichthyosis	DERM	313	242,300	AR	5.41	0.06	0.176	0.916	0.74	4	8	9	2	1	0	0	null	Panel	21.36	0	1,500	1	NBS_followup	37,534.79	7.1	Delayed	61.1	65.5	42.5	65.8	95.3	0	0	0	5.02	2	0	null	0	92	0	0	1	0	0	1	0	0	0	0.22	-1.11	0	0	0	0	215.45	36.248	9.919	7.4	2.1	20	3	0.251	120.3	632.5	70.7	65.2	4,197.6	0	Supportive_only	null	null	null	null	null	4.88	0	Prior_auth_required	0	0	3.12	0	681	Intermediate	0.653	null	0	Not_applicable	0	null	0	0	Moderate	0	41	0	0	0	Assisted	Limited_verbal	0	0	Mainstream	0	4	0	null	null	0	39.6	7.3	9.6	1	38,173	6.1	2,035	59.9	55.3	51.3	18.7	70	48.2	0	0	0	1	0	0	0	120.2	17	1	0	0	1	0	0	2	1.92
HCG5-0000024	Male	Black_non_Hispanic	Asia_Pacific	Urban	High	English	Commercial	Achondroplasia	SKEL	15	100,800	AD	3.86	0.04	0.057	0.28	0.223	4	6	6	3	0	0	0	null	Panel	3.14	0	1,500	1	Geneticist	100,243.68	6.54	Delayed	92.7	68.1	55.9	17.7	61.5	0	0	0	7.38	0	0	null	0	125	0	0	1	1	0	0	0	0	1	-0.66	-0.86	0	1	1	0	204.69	9.38	8.568	22.73	2.32	20	1.32	0.122	192	430	20.5	28.8	3,115.3	0	Small_molecule	null	null	null	Supportive_metabolic	1.69	4	1,532,687	Partial_coverage	0	0	8.79	0	593	High_value	0.404	0.671	0	Responder	0	null	0	0	Stable	3	8	1	0	0	Ambulatory	Verbal	0	0	Mainstream_with_support	0	4	0	null	null	0	47.6	1.8	1.9	1	117,839	7	1,771	35.3	94.7	89.9	72.4	14.8	66.5	0	0	1	1	0	0	0	83.5	16	0	0	0	0	0	0	2	0.63
HCG5-0000025	Male	White_non_Hispanic	North_America	Urban	Low	English	Medicaid_CHIP	MPS_I_Hurler	LSD	579	607,014	AR	8.71	0.8	0.012	0.012	0	0	1	16	0	0	1	1	4.5	Single_gene	4.4	0	800	0	NBS_followup	33,557.57	5.12	Profound_delay	51.5	95.9	34.3	56.3	63.4	0	0	1	5.23	2	0	null	1	43.1	1	1	0	1	0	0	1	0	1	-2.27	-0.94	0	0	1	1	135.74	126.936	30.838	8.77	5.77	20.2	1.58	0.119	193.8	317.1	31.3	138.9	2,109.3	1	ERT	Laronidase	null	null	null	0.91	14.69	136,032	Prior_auth_required	0	0	6.14	1	685	Low_value	0.255	0.766	1	Partial	1	MUD	0	1	Stable	7	5	2	0	0	Bedbound	Nonverbal	1	0	Special_ed	1	2	1	18	Neurodegeneration	0	44.7	6.5	14.8	1	12,824	6.9	8,197	43.3	44.3	72.4	54.7	55.9	23.8	1	0	1	0	0	1	0	12	5	0	0	0	0	0	0	9	0
HCG5-0000026	Female	Asian	North_America	Suburban	High	English	Medicaid	Leigh_syndrome	MITO	506	256,000	MT	9.14	0.68	1.317	16.317	15	3	7	25	10	0	0	0	null	WES	7.31	0	4,500	1	Neurologist	12,899.43	7.52	Profound_delay	34.9	20.5	10	23.3	32.6	0	0	1	1.33	3	1	Moderate	0	93.3	0	0	0	1	1	1	1	1	0	-3.91	1.91	0	1	0	0	1,343.64	4.808	7.517	3.3	3.85	20	2.25	0.169	439.5	314.4	18.7	801.6	1,137.6	0	Supportive_only	null	null	null	null	null	4.51	0	Partial_coverage	0	0	6.79	0	3,954	Intermediate	0.776	null	0	Not_applicable	0	null	0	0	Slow_progression	0	36	0	1	0	Bedbound	Nonverbal	0	1	Special_ed	0	6	1	18	Cardiac	1	33.5	14.2	12.4	0	0	4.9	12,916	37.7	38	67.1	40.8	55.2	65.4	1	0	1	1	0	0	1	51.4	46	1	0	0	0	0	0	4	0
HCG5-0000027	Female	White_non_Hispanic	Europe	Urban	High	Arabic	Medicaid	Gaucher_type1	LSD	355	230,800	AR	5.56	0.05	4.126	11.968	7.842	2	8	6	2	0	0	0	null	Panel	60.34	0	1,500	1	Metabolic_specialist	103,125.77	5.72	Delayed	33.6	51.8	64.4	76.9	56.9	1	0	0	2.12	0	0	null	0	75	0	0	0	0	1	0	1	1	0	-4.75	2.68	0	0	1	0	149.93	11.74	8.665	3.74	9.65	20	4.68	0.223	254	217.2	11	27.6	383.4	1	Small_molecule	null	null	null	Eliglustat	12.17	13.88	315,294	Denied	1	0	6.85	0	8,671	Cost_saving	0.223	0.873	0	Responder	0	null	0	0	Slow_progression	11	7	1	0	0	Assisted	Limited_verbal	0	0	Special_ed	0	6	0	null	null	0	77.3	19.9	9.4	1	51,831	5.2	13,572	74.1	48.7	61.4	34.7	43.4	46	1	0	1	1	0	0	0	39.2	11	1	1	0	0	0	0	3	2.39
HCG5-0000028	Female	Hispanic	North_America	Urban	High	Spanish	Commercial	Pompe_late_onset	LSD	365	232,300	AR	4.58	0.1	0.009	0.009	0	0	3	3	0	0	1	1	3.1	Single_gene	0.29	0	800	1	NBS_followup	22,814.23	7.47	Delayed	79.6	85.1	61.6	102.6	55.8	0	0	0	3.81	0	1	Severe	0	59.7	0	0	0	0	1	0	1	1	1	0.61	-0.02	0	0	1	0	210.46	6.182	7.119	4.66	2.88	36.6	2.34	0.204	396.4	500.4	43.3	444.5	402.5	1	HSCT	null	null	null	null	0.73	13.9	273,059	Prior_auth_required	0	0	6.02	1	32,541	High_value	0.271	0.774	0	Responder	0	null	0	0	Slow_progression	2	22	0	0	0	Assisted	Limited_verbal	0	0	Special_ed	1	4	0	null	null	0	34.4	13.4	11.4	1	30,730	5.5	20,140	63	50.1	50.8	75.9	55	30.5	1	0	1	1	0	1	0	98.2	6	0	0	0	0	0	0	4	0.46
HCG5-0000029	Male	White_non_Hispanic	North_America	Suburban	Middle	English	Medicaid_CHIP	MLD	LD	512	250,100	AR	8.01	0.7	0.008	0.008	0	0	5	13	3	0	1	1	2.9	Panel	1.51	0	1,500	1	NBS_followup	53,971.43	4.42	Profound_delay	25.3	31.1	48.9	43.2	69.3	0	0	1	1.22	2	1	Moderate	0	114.1	1	0	0	1	0	0	0	0	0	-2.01	-1.06	0	1	0	0	34.85	45.616	6.171	0.89	1.57	20	2.31	0.122	329.8	424.5	168.5	119.9	6,722.1	1	Gene_therapy	null	Atidarsagene_autotemcel	null	null	5.94	9.26	1,166,037	Prior_auth_required	0	0	3.36	0	1,556	Intermediate	0.42	0.847	0	Responder	0	null	0	0	Stable	3	16	2	0	0	Bedbound	Nonverbal	1	0	Special_ed	0	1	1	4.32	Respiratory_failure	1	29.7	10.4	14.3	1	14,646	7.1	7,048	45.7	54.6	56.9	0	32.9	56.9	1	0	0	1	0	1	1	108	49	0	0	0	0	0	0	3	0.57
HCG5-0000030	Female	Black_non_Hispanic	North_America	Urban	Middle	Mandarin	Medicaid	OI_type1_to_4	SKEL	666	166,200	AD	6.61	0.06	0.541	2.878	2.337	4	16	14	3	0	0	0	null	WES	9.16	0	4,500	0	Metabolic_specialist	15,496.88	6.4	Regression	63.9	38.3	26.1	65.3	48	0	1	0	2.6	2	0	null	1	48.3	0	0	1	0	0	0	1	0	0	-0.88	-2.53	0	0	0	0	95.93	36.077	6.521	4.57	8.83	20	1.18	0.226	193.7	488.6	23.4	76	9,891.6	1	Small_molecule	null	null	null	Supportive_metabolic	3.44	13.61	91,608	Fully_covered	0	0	9.89	1	1,366	Intermediate	0.478	0.693	0	Partial	0	null	0	0	Slow_progression	5	9	1	0	1	Wheelchair	AAC_device	0	0	Mainstream	1	2	0	null	null	0	37.4	22	20.3	1	41,674	5.3	1,145	73.5	34	30.8	46.5	13.8	50	1	0	0	1	0	0	0	57.5	24	1	1	0	1	0	0	3	4.71
HCG5-0000031	Female	Hispanic	North_America	Urban	Middle	English	Medicaid	22q11_2_DiGeorge	SYN	567	188,400	AD	4.35	0.08	0.644	1.785	1.141	4	11	11	0	1	0	0	null	MLPA	1.53	0	1,000	1	Metabolic_specialist	29,193.47	6.79	Delayed	73.2	94.5	84.3	72.4	91.7	0	1	0	1.92	0	1	Mild	1	70.3	0	0	1	1	0	0	0	0	0	-2.94	-2.64	0	0	0	0	104.51	7.416	60.052	7.15	2.51	20	6.16	0.129	555.8	379.7	83.4	357.2	2,058.2	0	Small_molecule	null	null	null	Supportive_metabolic	2.87	20.05	644,401	Prior_auth_required	0	0	8.99	1	540	Cost_saving	0.284	0.916	0	Partial	0	null	0	0	Slow_progression	0	7	1	1	1	Assisted	Limited_verbal	0	0	Special_ed	1	5	0	null	null	0	57.6	11.6	13.4	1	48,566	6.2	10,058	31.9	100	83.9	52.9	67.2	70.3	1	0	1	1	1	1	1	77.1	6	1	0	0	1	0	0	4	4.01
HCG5-0000032	Male	White_non_Hispanic	Europe	Urban	Middle	English	Medicaid_CHIP	PA	OA	35	606,054	AR	7.03	0.5	0.032	0.032	0	0	2	10	2	0	1	1	11.9	WES	2.13	0	4,500	0	NBS_followup	13,080.25	2.78	Regression	29.8	67.9	86.5	64.3	46.2	1	0	0	5.72	4	0	null	0	82.6	0	0	0	1	0	0	0	0	0	-2.17	1.92	1	1	1	0	294.8	54.457	30.169	18.51	1.63	35.4	4.32	0.216	20	404.6	93.1	1,034.4	306.8	0	Supportive_only	null	null	null	null	null	8.93	0	Prior_auth_required	0	0	3.03	0	3,549	High_value	0.022	null	0	Not_applicable	0	null	0	0	Moderate	1	23	3	0	0	Wheelchair	AAC_device	1	0	Home_school_medical	1	5	1	12.13	Cardiac	1	55.6	4.9	5	1	73,379	6.9	19,703	35.3	60.7	49.7	40	88.5	41.7	0	0	0	1	0	0	0	60	17	1	0	0	1	0	1	4	3.36
HCG5-0000033	Female	Asian	Asia_Pacific	Urban	Low	English	Medicaid	MSUD	OA	511	248,600	AR	6.19	0.55	0.003	0.003	0	0	2	7	0	0	1	1	1	WES	0.16	0	4,500	1	NBS_followup	35,955.38	7.09	Regression	64.4	70.8	87.9	61.7	59	0	0	0	0.69	0	1	Mild	0	115.4	0	0	0	0	0	0	0	0	1	-2.11	-2.75	1	1	0	0	83.49	11.838	15.056	10.73	7.42	1,034.9	4.63	0.185	159.1	314.8	74.1	1,271.3	835.2	0	Supportive_only	null	null	null	null	null	5.9	0	Fully_covered	0	0	9.71	0	232	High_value	0.426	null	0	Not_applicable	0	null	0	0	Slow_progression	1	19	2	0	0	Wheelchair	AAC_device	0	0	Mainstream	1	5	1	11.13	Infection	1	71.9	18.9	21	0	0	5.9	3,224	77.3	42.2	52.5	53.8	29.9	70.6	0	1	1	1	0	1	0	27	29	0	0	0	0	0	0	7	0.39
HCG5-0000034	Male	White_non_Hispanic	North_America	Urban	High	Other	Commercial	Leigh_syndrome	MITO	506	256,000	MT	8.47	0.68	0.33	4.136	3.806	3	9	10	0	0	0	0	null	WGS	8.23	0	8,500	1	Neurologist	55,461.55	2.38	Profound_delay	48.4	51	80.7	35.2	51.7	1	0	1	5.02	1	0	null	0	66.1	0	0	1	1	0	1	1	1	0	-1.51	-1.1	0	0	0	0	190.24	31.456	7.443	20.99	12.24	20	0.93	0.151	123.4	625.4	180.8	334.3	794.8	0	Supportive_only	null	null	null	null	null	24.65	0	Fully_covered	0	0	3.81	0	775	High_value	0.232	null	0	Not_applicable	0	null	0	0	Moderate	4	42	0	0	1	Bedbound	Nonverbal	1	0	Special_ed	1	3	1	18	Respiratory_failure	1	34.6	17.4	5.5	1	26,176	7.9	5,233	60.4	34.2	21.2	26.1	45.1	51.2	0	1	0	1	1	0	0	199.3	19	1	0	0	0	0	0	5	0.75
HCG5-0000035	Male	Black_non_Hispanic	Europe	Suburban	Middle	Spanish	Commercial	MPS_I_Hurler	LSD	579	607,014	AR	8.91	0.8	1.422	3.39	1.968	1	4	18	5	1	1	0	null	Panel	33.26	1	1,500	1	Immunologist	17,234.71	8.59	Profound_delay	45.6	31.6	38.5	24.9	51.7	0	0	1	2.85	1	0	null	1	80.6	0	0	1	1	0	1	1	1	1	-1.69	-0.15	0	0	0	1	98.85	38.858	7.417	17.19	3.92	64.6	2.75	0.133	282.4	494.3	87.2	226.5	1,037.1	1	Small_molecule	null	null	null	Supportive_metabolic	3.6	13.47	352,993	Prior_auth_required	0	0	12.03	1	4,182	High_value	0.355	0.71	0	Non_responder	0	null	0	0	Stable	1	28	1	0	0	Bedbound	Nonverbal	1	1	Special_ed	1	6	1	17.39	Respiratory_failure	0	44.9	15.1	13.2	1	46,134	5.2	681	19.2	37.5	35	61.1	13.1	59.1	1	0	1	1	0	0	0	97.9	17	1	1	0	0	0	0	0	2.37
HCG5-0000036	Female	White_non_Hispanic	Asia_Pacific	Rural	Middle	Spanish	Medicaid	Pompe_infantile	LSD	365	232,300	AR	6.63	0.85	0.022	0.022	0	0	3	8	1	1	1	1	8.1	WES	0.65	0	4,500	1	NBS_followup	16,384.53	6.25	Regression	59.6	54.1	46.2	87.1	41.2	0	1	0	2.49	0	1	Mild	1	74.7	0	0	0	0	1	0	0	1	1	-2.91	-4.56	1	0	0	0	60.3	17.807	8.759	13.68	1.34	49.9	1.27	0.174	114.3	398	158.1	376.4	746.4	1	Gene_therapy	null	Clinical_trial	null	null	2.78	16.38	383,618	Denied	1	1	6.43	1	302	Intermediate	0.274	0.624	0	Partial	0	null	0	0	Stable	4	8	0	0	0	Wheelchair	AAC_device	0	0	Special_ed	1	2	0	null	null	0	61.5	22.7	9.6	1	88,148	6.5	4,537	57.4	43.8	100	100	53.1	44.7	1	0	1	0	0	1	1	420.3	12	1	0	0	0	1	0	2	1.89
HCG5-0000037	Male	White_non_Hispanic	Asia_Pacific	Urban	Middle	English	Commercial	Leigh_syndrome	MITO	506	256,000	MT	7.22	0.68	0.96	1.929	0.97	0	9	12	2	0	0	0	null	Single_gene	4.46	0	800	1	Cardiologist	37,091.25	6.7	Regression	41.4	53.8	59.7	61.4	73.6	1	0	1	4.72	2	1	Severe	1	15.5	1	0	1	1	0	1	1	1	0	-2.92	-2.4	0	0	0	0	57.9	50.343	60.95	4.58	13.21	80.1	3.54	0.171	472.8	341.3	20	3,731.8	3,043	0	Supportive_only	null	null	null	null	null	18.93	0	Partial_coverage	0	0	9.53	0	2,401	High_value	0.225	null	0	Not_applicable	0	null	0	0	Moderate	3	28	2	0	1	Wheelchair	AAC_device	0	0	Home_school_medical	1	6	0	null	null	0	33.1	12.5	10.2	0	0	6.3	29,666	29.2	55.8	46.1	35.7	32.6	35.4	0	0	0	0	0	0	0	42.2	6	1	0	0	1	0	0	5	1.22
HCG5-0000038	Male	White_non_Hispanic	Asia_Pacific	Suburban	Low	English	Medicaid	MPS_III_Sanfilippo	LSD	581	252,900	AR	6.79	0.7	3.808	12.484	8.676	2	9	10	1	0	0	0	null	Single_gene	24.54	0	800	1	NBS_followup	12,803.65	6.49	Regression	66.5	74	47.4	71.6	54.6	0	0	1	1.17	6	0	null	0	76.6	0	0	0	0	1	0	0	1	1	-1.9	-2.54	0	0	0	1	152.41	19.498	15.829	5.91	4.66	27.2	2.7	0.109	584.3	150.8	75.3	177.3	2,315.5	0	Small_molecule	null	null	null	Supportive_metabolic	14.25	11.74	323,788	Fully_covered	0	0	7.83	1	11,093	Intermediate	0.372	0.769	0	Responder	0	null	0	0	Moderate	7	31	2	0	0	Wheelchair	AAC_device	0	0	Home_school_medical	1	6	0	null	null	0	63.7	14.7	12.6	1	24,482	6	3,849	45.3	50.2	78.5	63	44.6	65.5	0	0	0	1	0	0	0	27.5	9	1	0	0	0	0	0	1	0
HCG5-0000039	Female	White_non_Hispanic	Europe	Suburban	Middle	Spanish	Medicaid	MLD	LD	512	250,100	AR	9.45	0.7	0.009	0.009	0	0	1	14	4	0	1	1	3.2	WES	0.86	0	4,500	1	NBS_followup	6,862.66	6.52	Profound_delay	26.2	49.5	10	46.2	57.2	0	0	0	0.43	1	0	null	1	77.5	1	0	0	1	1	0	1	0	0	-3.91	-1.47	0	0	0	0	200.95	30.11	23.874	1.18	4.05	275.3	3.04	0.21	46.5	135.3	128.7	852.7	8,778.5	1	Supportive_only	null	null	null	null	null	6.83	0	Fully_covered	0	0	6.36	0	1,192	Intermediate	0.306	null	1	Not_applicable	0	null	0	0	Rapid	11	23	0	1	0	Bedbound	Nonverbal	1	1	Home_school_medical	1	4	1	11.06	Metabolic_crisis	1	50	8	13.6	0	0	3.2	2,088	54.6	65.6	29.2	52.1	62.9	51.8	0	0	0	0	0	0	1	5.1	4	1	1	0	0	0	0	3	3.3
HCG5-0000040	Female	White_non_Hispanic	Asia_Pacific	Urban	Middle	English	TRICARE	ASS1_citrullinemia	UCD	247,525	215,700	AR	5.21	0.4	0.233	1.255	1.021	0	5	11	3	0	0	0	null	Panel	7.35	0	1,500	1	Neurologist	36,970.54	6.82	Delayed	46.8	50.1	80.8	84.7	69.5	0	0	0	2.14	6	1	Mild	0	124	0	0	0	1	1	0	0	0	0	-2.79	0.01	1	0	0	0	149.35	17.345	14.583	4.97	2.31	95.5	1.45	0.263	320	303.6	26	127.5	1,225.2	1	SRT	null	null	null	null	8.98	5.06	230,607	Fully_covered	0	0	8.97	0	2,389	Low_value	0.269	0.745	0	Partial	0	null	0	0	Moderate	0	19	2	0	0	Assisted	Limited_verbal	0	0	Special_ed	1	6	1	12.03	Other	0	35	8.3	17.2	0	0	5.5	42,620	56.4	29.9	36.4	62.5	58.1	43.9	0	0	0	1	0	0	1	663	4	1	0	1	0	0	0	0	4.19
HCG5-0000041	Male	Hispanic	North_America	Suburban	Middle	Other	Commercial	WAS_Wiskott	IMM	906	301,000	XLR	7.41	0.55	0.484	3.722	3.238	4	13	21	1	1	0	0	null	WES	39.45	0	4,500	1	Metabolic_specialist	24,417.92	5.03	Regression	64	69.1	43.2	34.8	69.9	0	1	1	1.97	6	0	null	1	70.7	0	0	0	0	0	0	0	0	0	-1.98	1.24	0	0	0	0	78.82	4.131	5.49	7.05	9.18	97.7	1.19	0.233	52.6	688.4	10	98.1	2,208.8	1	Supportive_only	null	null	null	null	null	9.05	0	Prior_auth_required	0	0	14.27	0	773	High_value	0.594	null	0	Not_applicable	1	MSD	0	1	Moderate	2	20	0	0	0	Wheelchair	AAC_device	0	0	Mainstream	1	5	1	13.64	Respiratory_failure	0	23.9	10.4	7.6	0	0	3.7	11,103	50.2	41.8	57	44.2	43.6	66.8	0	1	1	0	0	0	1	94.1	28	1	0	0	0	0	0	2	0
HCG5-0000042	Male	Black_non_Hispanic	North_America	Suburban	Low	Spanish	TRICARE	X_ALD	LD	43	300,100	XLR	8.36	0.55	0.018	0.018	0	0	2	9	4	0	1	1	6.5	WES	0.34	0	4,500	1	NBS_followup	23,957.26	4.38	Profound_delay	62.5	16.3	10.7	47.2	42.5	0	0	1	0.67	2	0	null	1	46.3	0	0	0	1	0	0	1	0	0	-1.32	-1.46	0	0	0	0	157.94	19.862	13.361	3.57	1.22	20	1.52	0.187	435.1	256.6	18.4	1,712.6	3,793.8	1	Supportive_only	null	null	null	null	null	16.94	0	Fully_covered	0	0	7.45	0	5,746	Intermediate	0.241	null	0	Not_applicable	1	MMUD	0	1	Slow_progression	6	31	1	0	1	Bedbound	Nonverbal	1	0	Special_ed	1	1	1	5.19	Metabolic_crisis	1	56	17.7	13.1	1	28,300	5.2	9,663	34.3	20.2	56.7	51.7	23.4	75.7	0	0	1	1	0	0	1	125.5	14	0	1	0	1	0	0	11	4.02
HCG5-0000043	Female	Hispanic	North_America	Rural	Low	English	Medicaid	MMA	OA	27	251,000	AR	7.73	0.45	0.014	0.014	0	0	4	7	1	0	1	1	5	Single_gene	0.7	1	800	1	NBS_followup	43,000.34	7.63	Regression	60.7	46	35.2	59.4	37.8	0	1	0	2.78	6	0	null	0	66.7	0	0	0	0	1	0	1	0	0	0	-1.14	1	1	1	0	131.27	10.112	4.626	1.31	1.12	41.9	2.68	0.138	139.8	261.7	26.9	245.4	5,022.4	0	Small_molecule	null	null	null	Supportive_metabolic	0.1	17.84	255,724	Fully_covered	0	0	7.34	0	2,906	High_value	0.375	0.636	0	Non_responder	0	null	0	0	Rapid	4	35	2	0	0	Wheelchair	AAC_device	0	0	Special_ed	1	3	0	null	null	0	68.8	9.3	14	1	21,720	5.7	7,015	71.5	32.1	45.3	57.1	60.7	42.7	0	0	1	1	0	0	0	349.4	2	1	0	0	1	0	0	15	0.22
HCG5-0000044	Male	White_non_Hispanic	Europe	Rural	Middle	Spanish	Medicaid	WAS_Wiskott	IMM	906	301,000	XLR	6.97	0.55	0.474	4.638	4.165	6	13	10	0	1	0	0	null	Panel	26.22	0	1,500	1	Geneticist	48,760.47	6.38	Regression	51	35.1	46.8	79.2	69	0	0	1	2.62	7	0	null	1	67.5	1	0	0	0	1	0	1	0	0	-2.37	-0.59	0	0	0	0	63.95	77.715	35.723	15.9	18.27	20	1.92	0.174	93.2	224.5	66.2	313.3	525.9	1	Chaperone	null	null	null	null	5.14	11.68	441,337	Partial_coverage	0	0	4.86	0	2,622	Cost_saving	0.413	0.887	0	Partial	0	null	0	0	Slow_progression	9	41	4	0	0	Wheelchair	AAC_device	0	0	Mainstream	1	1	1	11.79	Other	0	52.3	12.5	21	0	0	8.6	3,058	61.5	33.6	58.1	70.6	22.9	76.9	1	0	0	0	0	0	0	62.7	10	0	0	0	1	1	1	2	5.27
HCG5-0000045	Male	White_non_Hispanic	North_America	Urban	Middle	Other	Medicaid_CHIP	SCID	IMM	183	300,400	XLR	9.42	0.92	0.218	2.416	2.197	2	13	14	2	0	1	0	null	WES	3.22	0	4,500	0	Metabolic_specialist	23,274.14	4.6	Profound_delay	10	25.3	34.3	89.6	34.5	0	0	0	0.65	1	1	Mild	1	45.6	1	0	0	1	0	0	0	0	0	-1.76	-1.69	0	0	0	0	196.98	6.503	6.21	6.2	1.53	20	2.59	0.157	31.4	191.5	30.1	446.6	2,710.4	1	Small_molecule	null	null	null	Supportive_metabolic	2.79	14.69	267,980	Partial_coverage	0	0	1.3	1	1,031	Intermediate	0.116	0.743	0	Responder	0	null	0	0	Slow_progression	2	17	0	1	0	Bedbound	Nonverbal	1	1	Special_ed	1	6	1	6.01	Neurodegeneration	1	55.1	12.5	13.9	1	76,471	6.7	4,613	32	52.2	38.6	63.8	70.5	40	0	0	1	1	0	0	0	24.6	31	0	1	0	0	0	1	6	4.24
HCG5-0000046	Male	White_non_Hispanic	North_America	Urban	High	English	Medicaid_CHIP	GA_1	OA	25	231,670	AR	8.74	0.4	0.013	0.013	0	0	2	9	5	1	1	1	4.8	WES	6.51	0	4,500	1	NBS_followup	9,794.71	7.58	Profound_delay	69.8	82.4	39.3	50.9	81.4	0	0	1	2.05	5	0	null	0	79.6	0	0	0	0	0	0	0	0	1	-4.04	0.27	1	1	1	0	1,108.02	66.854	7.281	17.75	7.88	20	1.2	0.174	219.1	231.1	44.8	91.7	2,093.6	0	Supportive_only	null	null	null	null	null	2.96	0	Prior_auth_required	0	0	6.89	0	16	Intermediate	0.219	null	0	Not_applicable	0	null	0	0	Slow_progression	10	46	4	0	0	Bedbound	Nonverbal	1	0	Special_ed	0	6	1	9.77	Respiratory_failure	1	52.7	13.3	5.4	1	26,363	4.6	31,614	50.3	25.8	77.7	76.4	45.4	55.4	1	0	1	1	0	0	0	145.2	11	1	0	1	0	0	0	2	0.81
HCG5-0000047	Male	Hispanic	Asia_Pacific	Urban	Low	Spanish	Other_public	MMA	OA	27	251,000	AR	7.37	0.45	0.01	0.023	0.013	0	4	11	0	0	1	1	8.5	WGS	0.89	1	8,500	1	NBS_followup	15,142.67	3.65	Regression	16.9	26.4	77.2	39.5	58.7	0	0	0	1.48	4	0	null	0	83.1	0	0	0	1	1	0	1	0	0	-1.4	0.32	1	1	0	0	156.09	18.899	25.327	8.12	11.48	33.8	2.22	0.24	61	419.6	29.3	151.1	2,447.4	0	Supportive_only	null	null	null	null	null	5.98	0	Fully_covered	0	0	2.14	0	3,755	Intermediate	0.413	null	0	Not_applicable	0	null	0	0	Rapid	5	31	5	1	0	Wheelchair	AAC_device	1	0	Special_ed	1	4	0	null	null	1	60.8	8.6	17.7	1	41,733	6	3,021	46	70.7	95.6	39	23.8	64.7	0	0	0	1	0	1	0	41.7	8	1	1	0	1	0	0	5	3.55
HCG5-0000048	Female	Hispanic	North_America	Urban	Low	Other	Medicaid	MLD	LD	512	250,100	AR	5.81	0.7	0.008	0.008	0	0	1	16	7	0	1	1	2.9	Panel	2.64	0	1,500	1	NBS_followup	45,545.52	4.01	Delayed	72.8	48.4	32.2	39.5	36.1	0	1	1	3.7	2	0	null	0	107.4	0	0	1	0	0	0	0	0	0	-2.89	-4.75	0	0	0	0	42.05	31.995	6.498	13.39	4.01	69.4	5.14	0.158	41.3	285.5	40.9	120.8	1,919.1	1	Supportive_only	null	null	null	null	null	20.86	0	Fully_covered	0	0	4.02	0	806	Intermediate	0.406	null	0	Not_applicable	0	null	0	0	Moderate	0	20	1	0	0	Assisted	Limited_verbal	1	1	Home_school_medical	1	0	1	4.39	Metabolic_crisis	1	63.8	11.5	8.2	0	0	6.3	23,514	45.6	76.5	80.4	60.8	17.1	0	0	1	1	1	0	0	1	7.3	5	1	0	0	1	0	0	0	1.4
HCG5-0000049	Male	White_non_Hispanic	North_America	Urban	Low	English	Commercial	Pompe_infantile	LSD	365	232,300	AR	10	0.85	0.003	0.003	0	0	1	9	1	0	1	1	1	WGS	2.64	0	8,500	1	NBS_followup	30,417.17	7.22	Profound_delay	73	47.7	26.8	17.8	29.1	0	0	1	0.59	3	1	Severe	1	94.7	1	1	1	1	0	0	1	1	1	-2.17	0.62	0	1	0	0	787.25	6.411	10.003	11.36	1.5	144.6	2.72	0.079	305.9	279.1	42.7	352.6	10,025.3	1	Gene_therapy	null	Clinical_trial	null	null	0.45	3.99	74,872	Fully_covered	0	0	3.07	0	792	Intermediate	0.278	0.632	0	Responder	0	null	0	0	Stable	1	8	2	1	0	Bedbound	Nonverbal	1	1	Home_school_medical	1	5	1	8.54	Respiratory_failure	1	9.6	7.1	7.2	0	0	5.9	8,511	47.6	49.2	26.2	44.8	32.7	37.4	0	1	0	0	0	0	0	284.9	14	1	0	0	0	0	0	5	0.19
HCG5-0000050	Male	Hispanic	North_America	Rural	Middle	Other	Commercial	MPS_II_Hunter	LSD	580	309,900	XLR	8.48	0.72	0.871	5.434	4.562	0	9	11	1	0	0	0	null	Panel	9.47	0	1,500	1	Geneticist	16,402.95	5.7	Profound_delay	47.6	38.5	22.2	30.2	28.8	0	0	1	3.12	0	0	null	1	77.6	1	0	1	1	1	0	0	1	1	-1.23	-0.2	0	0	0	1	637.22	16.812	1.134	2.6	5.85	135.4	2.82	0.228	783	266.9	28.7	366.2	741.9	1	ERT	Idursulfase	null	null	null	6.84	11.65	25,714	Partial_coverage	0	0	3.5	1	51,763	High_value	0.415	0.466	0	Partial	0	null	0	0	Rapid	3	34	5	0	0	Bedbound	Nonverbal	1	0	Mainstream	1	1	1	12.51	Respiratory_failure	1	44.3	13.3	17.8	0	0	5.8	8,556	78.9	16.7	63.7	68.4	35.9	44.9	1	0	0	1	0	1	0	16.1	16	1	1	0	0	0	0	3	1.58
HCG5-0000051	Male	White_non_Hispanic	Europe	Urban	Middle	English	Commercial	Gaucher_type1	LSD	355	230,800	AR	4.96	0.05	1.013	4.316	3.303	5	20	17	1	1	0	0	null	Single_gene	6.83	1	800	0	Other	13,280.5	7.29	Delayed	73	72.2	91.7	12.6	94.8	0	0	1	2.48	3	0	null	1	55.2	1	1	1	0	1	0	0	1	1	-1.18	0.01	0	0	1	0	759.4	12.205	9.113	2.98	11.62	55.1	2.83	0.194	392.8	411	79.4	126.4	699.2	1	ERT	Taliglucerase	null	null	null	5.05	10.56	268,017	Fully_covered	0	0	3.71	1	4,990	High_value	0.468	0.67	0	Partial	0	null	0	0	Stable	9	32	2	0	0	Assisted	Limited_verbal	1	0	Mainstream	1	1	0	null	null	0	37.3	12.3	10.9	1	147,067	5.1	1,130	42	78.8	51.2	27.7	62.6	53.2	0	0	1	1	0	0	1	23.8	15	0	0	1	0	0	0	4	3.17
HCG5-0000052	Male	White_non_Hispanic	North_America	Urban	Middle	Spanish	Medicaid	Hypophosphatasia	SKEL	436	241,500	AR	4.62	0.25	1.848	7.528	5.68	4	10	12	1	0	0	0	null	WES	10.56	0	4,500	0	Geneticist	46,912.55	2.28	Delayed	76.8	98.5	55.8	57.1	90.2	0	0	1	3.77	0	0	null	0	68.2	0	0	0	0	0	0	1	0	1	-3.54	1.49	1	0	0	0	173.78	147.366	20.798	3.18	4.52	39.6	1.64	0.176	43.9	443.7	117.5	2,276.8	795.5	1	Gene_therapy	null	Clinical_trial	null	null	7.95	8.8	250,295	Partial_coverage	0	0	10.35	1	2,021	Low_value	0.526	0.743	0	Non_responder	0	null	0	0	Stable	14	8	0	0	0	Assisted	Limited_verbal	1	0	Mainstream	1	0	0	null	null	0	48.3	12.8	9.2	0	0	6.2	9,183	68.6	42.5	51.8	81.7	30.8	48.7	0	0	0	1	0	1	1	126.5	2	1	1	0	0	0	0	4	1.93
HCG5-0000053	Female	White_non_Hispanic	North_America	Suburban	High	Mandarin	Commercial	Myotonic_congenital	NM	590	160,900	AD	5.14	0.1	2.34	7.39	5.05	1	5	20	3	1	0	0	null	Panel	22.48	0	1,500	1	Geneticist	22,037.76	7.75	Delayed	70.1	80.6	56.8	80.2	68.8	0	0	1	0.63	1	0	null	0	102.7	0	0	1	0	0	0	0	0	0	-0.84	-3.26	0	0	0	0	82.8	11.936	6.933	2.07	1.7	23.2	5.92	0.103	207.7	143.4	20	237.4	1,352.6	0	HSCT	null	null	null	null	7.77	21.05	427,656	Partial_coverage	0	0	9.02	0	11,220	Intermediate	0.54	0.615	0	Non_responder	0	null	0	0	Slow_progression	2	8	0	1	0	Assisted	Limited_verbal	0	0	Home_school_medical	0	0	0	null	null	0	40.6	15.9	18.7	1	60,361	6.1	5,628	72.5	42.8	75.3	65	69.4	9.6	0	0	0	1	0	0	0	5.9	10	1	0	0	0	0	0	0	0
HCG5-0000054	Male	White_non_Hispanic	North_America	Urban	Low	Spanish	Medicaid	X_ALD	LD	43	300,100	XLR	6.45	0.55	0.007	0.007	0	0	1	18	3	0	1	1	2.4	Single_gene	0.41	0	800	1	NBS_followup	52,968.1	6.74	Regression	100.4	51.1	76.9	59.5	69	0	0	0	3.05	8	0	null	0	124.6	0	0	0	0	0	0	1	1	0	-1.85	-2.41	0	0	0	0	74.22	62.68	20.153	18.4	4.37	25.9	2.76	0.118	553.7	249.6	52	274	2,424.3	1	Supportive_only	null	null	null	null	null	12.81	0	Fully_covered	0	0	7.39	0	1,354	Intermediate	0.638	null	0	Not_applicable	1	MSD	0	1	Slow_progression	1	6	1	0	0	Wheelchair	AAC_device	0	0	Mainstream	1	6	1	8.99	Respiratory_failure	0	53.4	23.8	8	0	0	6.6	1,196	62.7	55.9	61.3	79.8	0	43.8	0	1	1	1	0	1	0	59.4	22	1	1	0	1	1	0	0	4.43
HCG5-0000055	Male	Hispanic	Asia_Pacific	Urban	Middle	English	Commercial	Achondroplasia	SKEL	15	100,800	AD	2.54	0.04	0.041	0.116	0.075	0	9	9	3	0	0	0	null	Panel	3.31	0	1,500	1	Other	59,361.56	7.31	On_track	68.3	81.7	110	78.6	83.3	1	1	0	2.06	7	0	null	0	110.1	0	0	0	0	1	0	0	0	1	-0.28	-0.51	0	0	0	0	567.49	63.474	12.007	4.64	0.95	20	2.48	0.124	207.7	349.1	16.4	1,072.6	1,145.8	0	Supportive_only	null	null	null	null	null	2.67	0	Fully_covered	0	0	19.86	0	1,318	Intermediate	0.439	null	0	Not_applicable	0	null	0	0	Moderate	4	53	2	1	0	Ambulatory	Verbal	0	0	Special_ed	1	0	0	null	null	0	48.7	1.8	7	1	14,003	6.8	6,259	80.1	40.2	69.2	65.3	60.4	21.9	0	0	0	1	0	0	1	70.7	13	0	0	0	0	0	0	1	0
HCG5-0000056	Male	Asian	Latin_America	Rural	Low	Spanish	Medicaid_CHIP	Leigh_syndrome	MITO	506	256,000	MT	8.34	0.68	0.808	11.699	10.89	2	13	20	1	0	0	0	null	WGS	48.63	0	8,500	1	Neurologist	20,301.38	7.97	Profound_delay	28.4	58.4	72.6	15	70.6	0	0	1	5.31	0	1	Moderate	0	92.6	0	0	1	0	0	0	1	1	1	-0.05	-4.11	1	0	0	0	903.14	61.889	32.429	6.47	1.38	20.1	3.36	0.131	361.6	454.6	13.1	93.5	4,945.9	0	Supportive_only	null	null	null	null	null	17.6	0	Prior_auth_required	0	0	36	0	345	Cost_saving	0.17	null	0	Not_applicable	0	null	0	0	Slow_progression	3	25	1	0	0	Bedbound	Nonverbal	1	1	Mainstream	1	3	1	17.65	Metabolic_crisis	0	21.8	11.3	13.6	0	0	6.8	3,922	47.9	64.9	56.3	48	28.2	41.7	0	0	1	1	0	0	1	173.6	8	1	1	0	1	0	0	8	3.79
HCG5-0000057	Male	White_non_Hispanic	Europe	Urban	Low	English	Uninsured	SMA_type2	NM	83,418	253,550	AR	6.36	0.25	0.008	0.008	0	0	1	11	1	0	1	1	2.8	MLPA	0.53	0	1,000	1	NBS_followup	63,239.4	5.43	Regression	52.8	72.7	21	78.6	74.6	1	0	0	1.78	8	0	null	1	44.2	1	0	0	1	0	0	0	0	0	0.13	-0.74	0	0	0	0	72.21	13.007	6.287	1.55	2.63	60.1	3.91	0.136	144.8	389.1	92.3	138	1,801.7	1	Supportive_only	null	null	null	null	null	5.71	0	Partial_coverage	0	0	10.56	0	2,145	Intermediate	0.367	null	0	Not_applicable	0	null	0	0	Rapid	3	21	1	0	0	Wheelchair	AAC_device	0	0	Special_ed	1	4	0	null	null	0	16.6	7.4	0	0	0	5.9	7,824	63	61.8	42.3	42.8	51.1	44.4	0	0	1	1	0	0	1	104.1	24	1	0	0	0	0	0	0	0.49
HCG5-0000058	Female	Black_non_Hispanic	Europe	Urban	Middle	English	Commercial	Pompe_infantile	LSD	365	232,300	AR	8.44	0.85	0.018	0.018	0	0	3	14	1	0	1	1	6.7	Metabolic	1.57	0	900	1	NBS_followup	30,472.16	4.19	Profound_delay	76.5	48.1	51.1	54.9	66.5	0	0	0	3.81	8	1	Moderate	1	62.6	1	1	0	0	0	0	1	0	1	-3.51	0.95	1	0	1	0	14.58	112.664	9.802	8.63	3.51	316.2	1.05	0.103	154.2	550.8	182.2	335	1,641.9	1	ASO	null	null	Custom_ASO	null	1.43	2.22	210,390	Partial_coverage	0	0	15.14	1	10,061	Low_value	0.192	0.799	0	Responder	0	null	0	0	Stable	1	14	1	0	0	Bedbound	Nonverbal	1	1	Mainstream_with_support	0	4	0	null	null	0	59.3	15.4	11.9	1	35,622	5.6	2,556	51.1	99.1	35.9	43.3	70.4	55	0	0	0	1	0	1	1	119.1	8	1	0	0	0	0	0	10	0.71
HCG5-0000059	Male	Hispanic	Latin_America	Urban	Low	English	Commercial	Fabry	LSD	324	301,500	XLR	5.89	0.04	2.367	7.271	4.904	4	7	13	2	1	0	0	null	Panel	9.01	0	1,500	1	Cardiologist	34,234.27	6.5	Delayed	51.3	70.3	64.5	61.5	61.6	0	0	0	4.11	1	1	Mild	0	113.4	0	0	1	0	1	1	1	1	0	-1.32	0.23	0	0	1	0	178.08	135.77	3.246	3.23	1.13	29.7	2.3	0.391	110.9	180.2	35.5	48.3	478.1	1	ERT	Agalsidase_alfa	null	null	null	8.08	22.57	71,319	Fully_covered	0	0	8.6	1	1,159	Intermediate	0.572	0.651	0	Non_responder	0	null	0	0	Slow_progression	2	4	3	0	0	Assisted	Limited_verbal	0	0	Mainstream_with_support	0	5	0	null	null	0	35.1	17	10.9	1	25,625	6.7	2,175	32.2	53.3	54.9	16.4	70.2	42.4	0	0	1	0	0	1	1	143.8	12	0	0	0	1	1	0	0	4.9
HCG5-0000060	Male	Native_American	Sub_Saharan_Africa	Rural	Middle	English	Commercial	MLD	LD	512	250,100	AR	8.81	0.7	0.024	0.024	0	0	3	17	4	0	1	1	8.8	WES	0.94	0	4,500	1	NBS_followup	3,752.31	5.63	Profound_delay	50.5	52.3	37.3	10	35	0	0	1	2.14	2	0	null	0	93.1	0	0	1	1	0	1	1	1	0	-3.69	-0.27	0	0	0	0	73.39	30.889	11.214	12.29	4.16	20	8.51	0.301	510	449.3	161.3	188.4	11,171.2	1	ASO	null	null	Custom_ASO	null	0.14	2.71	1,038,811	Fully_covered	0	0	11.98	1	190	High_value	0.667	0.639	0	Responder	0	null	0	0	Slow_progression	1	23	4	1	0	Bedbound	Nonverbal	0	1	Special_ed	1	5	1	10.65	Neurodegeneration	1	73.1	6.4	6.9	1	36,237	4.8	6,601	29.2	35.9	50.7	47.3	50.3	52.4	1	0	0	1	0	1	0	268.9	24	0	0	0	0	0	1	1	2.55
HCG5-0000061	Male	Black_non_Hispanic	Europe	Urban	Middle	English	Commercial	Leigh_syndrome	MITO	506	256,000	MT	7.91	0.68	0.172	1.415	1.242	8	16	7	3	1	0	0	null	WGS	46.08	0	8,500	1	Geneticist	11,228.05	7.97	Regression	67.9	49.2	46.1	39.3	68.8	0	0	1	2.63	3	1	Severe	1	52.7	0	0	1	1	1	1	1	0	0	-0.24	-0.77	0	0	0	0	89.37	14.602	8.336	2.59	5.31	142.2	6.01	0.185	550.1	1,018.1	28.4	2,335.5	1,724.3	0	Supportive_only	null	null	null	null	null	6.75	0	Fully_covered	0	0	1.55	0	3,060	Intermediate	0.419	null	0	Not_applicable	0	null	0	0	Stable	3	10	0	1	0	Wheelchair	AAC_device	1	0	Special_ed	0	1	1	7.79	Infection	1	60.3	15.3	10.9	1	53,014	2.8	4,043	69.2	81.4	64.1	42	74.5	42.5	0	0	1	0	0	0	0	32.3	5	1	0	0	0	0	0	1	0.96
HCG5-0000062	Female	White_non_Hispanic	Latin_America	Urban	Middle	English	TRICARE	SMA_type1	NM	83,330	253,300	AR	8.75	0.9	0.015	0.021	0.006	0	4	13	1	0	1	1	7.7	Panel	1.01	0	1,500	1	NBS_followup	11,789.62	6.04	Profound_delay	57.1	34.2	65.7	51.3	83.4	0	1	0	6.85	1	0	null	1	39.9	0	0	0	1	0	0	0	0	0	-0.07	-1.08	0	0	0	0	142.85	10.231	28.908	13.01	2.74	20	2.09	0.163	125.7	373.9	37.9	1,829.7	9,293.8	1	Small_molecule	null	null	null	Supportive_metabolic	0.18	13.77	1,783,018	Prior_auth_required	0	0	0.59	0	6,502	Low_value	0.629	0.697	0	Responder	0	null	0	0	Stable	0	16	1	0	0	Bedbound	Nonverbal	1	1	Special_ed	1	4	0	null	null	0	24	18.8	12.5	1	18,235	3.7	4,283	39.9	1.4	71.4	52.5	73.2	57.1	0	0	0	1	1	1	0	17.9	12	1	0	0	0	0	1	0	1.65
HCG5-0000063	Female	Black_non_Hispanic	Latin_America	Urban	Middle	Other	Medicaid	Achondroplasia	SKEL	15	100,800	AD	3.45	0.04	0.054	1.921	1.866	1	10	9	2	0	0	0	null	Panel	7.72	0	1,500	1	Neurologist	20,195.41	4.96	Delayed	95.9	92.7	97.6	77	104.3	0	0	0	2.9	4	0	null	0	125	0	0	0	0	0	0	1	0	1	-0.63	-1.18	0	0	0	0	273.11	33.94	6.943	9.51	0.48	157.7	3.44	0.343	605.4	381.5	143.7	656.5	970.4	0	Supportive_only	null	null	null	null	null	9.2	0	Fully_covered	0	0	1	0	2,631	Intermediate	0.617	null	0	Not_applicable	0	null	0	0	Stable	6	18	0	1	0	Ambulatory	Verbal	0	0	Not_enrolled	1	4	0	null	null	0	33.6	14.6	9.6	0	0	3.6	1,771	55.5	59.2	61.8	48.3	90.2	26.7	0	1	0	1	1	0	1	19	7	0	0	0	0	0	0	3	0
HCG5-0000064	Female	White_non_Hispanic	Asia_Pacific	Urban	Middle	English	Other_public	CMT_1A_1B	NM	101,081	118,220	AD	3.7	0.02	8.938	18	15	2	7	8	8	1	0	0	null	Panel	8.42	0	1,500	1	Geneticist	29,819.44	9.11	Delayed	101.5	82.6	92.9	79.6	113.3	0	0	0	3.25	2	0	null	0	68.4	0	0	0	1	0	0	0	0	0	-2.31	-0.03	0	0	0	0	83.02	23.533	8.32	3.09	3.65	20	1.83	0.316	44.2	473.3	23.6	898.8	4,149	0	Small_molecule	null	null	null	Supportive_metabolic	18	5.02	61,314	Fully_covered	0	0	3.81	0	2,877	High_value	0.475	0.758	0	Non_responder	0	null	0	0	Stable	7	21	0	1	0	Ambulatory	Verbal	0	1	Mainstream_with_support	0	1	0	null	null	0	48.3	10.1	14	0	0	6.5	5,668	74.5	51.2	68	68.8	42.4	46.7	0	0	0	1	0	0	1	106.3	3	1	0	0	0	0	0	2	0
HCG5-0000065	Female	Other_Multi	Europe	Rural	Middle	English	Commercial	SMA_type1	NM	83,330	253,300	AR	10	0.9	0.505	3.246	2.74	2	9	8	0	1	1	0	null	WES	6.66	0	4,500	1	Geneticist	30,937.53	3.29	Profound_delay	40.5	10	34.3	48	45.6	1	0	0	3.73	5	0	null	1	33.4	1	0	0	1	0	0	0	1	0	-1.15	-2.88	0	0	0	0	207.7	26.166	6.635	13.93	17	91.8	2.75	0.123	199.3	277.9	84.9	421	1,030.1	1	ASO	null	null	Nusinersen	null	3.94	3.34	129,372	Denied	1	1	22.88	0	10,382	Low_value	0.515	0.817	0	Partial	0	null	0	0	Slow_progression	6	21	1	0	1	Bedbound	Nonverbal	0	1	Not_enrolled	1	3	1	12.92	Infection	0	43.8	18.1	12.8	0	0	6	11,396	42.8	59.6	69.5	45.3	56.4	34.5	1	0	1	0	0	0	0	38.9	6	1	0	0	0	0	0	7	0
HCG5-0000066	Female	White_non_Hispanic	North_America	Urban	Low	English	Commercial	SMA_type1	NM	83,330	253,300	AR	8.25	0.9	0.013	0.013	0	0	3	8	1	1	1	1	4.6	WES	0.56	0	4,500	1	NBS_followup	34,793.03	4.65	Profound_delay	38.2	33.2	89.9	49.3	30.8	0	0	0	2.85	8	0	null	1	58.6	0	0	0	0	0	0	0	0	1	-2.46	1.94	0	0	0	0	159.79	6.599	12.484	11.24	5.01	20	1.69	0.183	48.2	227.4	35	152.2	11,148.3	1	Supportive_only	null	null	null	null	null	4.32	0	Partial_coverage	0	0	8.41	0	324	Intermediate	0.591	null	0	Not_applicable	0	null	0	0	Stable	3	14	1	1	0	Bedbound	Nonverbal	1	0	Home_school_medical	1	4	1	15.96	Respiratory_failure	0	46.2	11.9	10.2	1	30,354	6.7	7,899	62.2	100	50.7	15.2	61.2	45	0	0	1	1	1	0	1	27.5	11	0	0	0	1	0	0	1	3.36
HCG5-0000067	Male	Hispanic	North_America	Rural	Low	English	Medicaid_CHIP	MMA	OA	27	251,000	AR	9.25	0.45	0.006	0.006	0	0	3	10	3	0	1	1	2.1	Panel	0.67	0	1,500	0	NBS_followup	14,523.89	7.48	Profound_delay	42.5	33.5	26.8	52.2	27	0	0	0	1.82	4	0	null	0	83.6	1	0	0	1	0	0	1	0	0	-1.78	-1.58	1	1	0	0	18.08	22.866	72.942	6.63	3.37	57.4	1.67	0.154	62.9	375.8	27	1,492.1	5,545.7	0	Small_molecule	null	null	null	Supportive_metabolic	0.18	3.05	931,776	Fully_covered	0	0	4.7	0	2,077	Cost_saving	0.169	0.457	0	Responder	0	null	0	0	Slow_progression	2	6	4	0	0	Bedbound	Nonverbal	1	0	Mainstream	1	4	0	null	null	0	33.9	19.2	14.8	1	199,522	6.4	4,152	45	23.8	61.7	50.5	42.1	55.5	0	1	0	1	0	0	0	174.1	6	1	0	0	1	0	0	3	1.81
HCG5-0000068	Male	White_non_Hispanic	Europe	Urban	Middle	Spanish	Commercial	Gaucher_type1	LSD	355	230,800	AR	5.7	0.05	4.438	9.087	4.649	1	15	16	0	0	0	0	null	Single_gene	58.16	0	800	1	Metabolic_specialist	50,122.57	7.77	Delayed	56.8	60.8	26.2	46.9	97.3	1	0	0	3.62	2	0	null	0	110.5	0	0	1	0	0	0	1	1	1	-1.91	0.49	1	1	1	0	312.62	62.145	0.523	2.02	2.37	676.1	1.56	0.148	47.5	159.7	31.3	86.2	4,228.2	1	ERT	Imiglucerase	null	null	null	10.35	8.68	496,286	Fully_covered	0	0	11.16	1	623	High_value	0.465	0.735	1	Non_responder	0	null	0	0	Moderate	1	14	2	0	0	Assisted	Limited_verbal	0	1	Mainstream_with_support	1	4	0	null	null	0	51.4	14.8	11.8	1	48,340	7	1,162	37.2	71	64.7	73.8	73.5	35	1	0	1	1	1	0	1	100.3	18	0	1	1	0	0	0	4	2.85
HCG5-0000069	Female	White_non_Hispanic	Europe	Urban	High	English	Medicaid	ASS1_citrullinemia	UCD	247,525	215,700	AR	4.21	0.4	0.174	0.939	0.765	1	7	8	2	1	0	0	null	WGS	22.45	0	8,500	1	NBS_followup	137,085.43	6.83	Delayed	118	96.7	64.9	49.4	34.6	0	0	1	5.4	4	0	null	0	111.3	0	0	0	0	0	0	0	0	1	-4.2	-0.27	1	0	0	0	115.47	46.232	11.669	8.5	5.58	20	6.11	0.155	111.4	445	10	710	875.9	1	Supportive_only	null	null	null	null	null	5.47	0	Fully_covered	0	0	9.19	0	4,091	Intermediate	0.52	null	0	Not_applicable	0	null	0	0	Moderate	6	50	3	0	0	Assisted	Limited_verbal	1	0	Mainstream_with_support	0	1	0	null	null	0	45.6	11.1	21	1	20,335	7.2	2,561	77.8	80.2	57.5	78.6	55.3	46.1	1	0	1	1	0	0	1	301.4	6	1	0	0	0	0	0	9	0
HCG5-0000070	Male	Hispanic	Europe	Rural	Low	English	Commercial	MPS_II_Hunter	LSD	580	309,900	XLR	8.1	0.72	2.244	9.993	7.748	2	7	18	0	0	0	0	null	WES	7.81	1	4,500	1	Geneticist	19,574.98	5.88	Profound_delay	37.7	110.6	44.5	56.4	86.1	0	0	0	3.78	8	0	null	1	28.3	0	0	0	1	1	0	1	0	0	-2.77	-2.25	1	0	0	1	51.22	15.291	35.056	4.72	4.01	20	1.67	0.16	514.8	484.1	108.1	139.8	12,169.2	1	Chaperone	null	null	null	null	11.91	2.19	927,260	Partial_coverage	0	0	1.97	1	2,526	Intermediate	0.162	0.753	0	Non_responder	0	null	0	0	Moderate	1	4	1	0	0	Bedbound	Nonverbal	1	0	Special_ed	1	5	1	15.06	Metabolic_crisis	0	59.1	5.9	16.1	0	0	6.9	2,852	34.9	67	31.7	34.3	12	45.5	1	0	1	1	0	1	1	72.6	3	1	0	0	0	0	0	0	2.09
HCG5-0000071	Male	Black_non_Hispanic	Europe	Urban	Middle	Other	Medicaid	OTC	UCD	664	311,250	XLR	9.25	0.52	0.61	2.801	2.191	0	13	13	1	0	0	0	null	Panel	29.42	1	1,500	1	NBS_followup	14,804.68	5.97	Profound_delay	48.6	10	62.6	52.8	29	0	1	0	4.65	4	0	null	0	71.4	0	0	0	1	1	0	0	1	0	0.93	1.67	1	0	0	0	87.71	20.123	7.667	4.66	6.28	40.8	4.42	0.18	222.7	163.7	52.4	149.3	13,876.8	1	HSCT	null	null	null	null	3.17	7.26	218,519	Denied	1	0	10.2	0	3,732	Intermediate	0.764	0.659	0	Partial	0	null	0	0	Slow_progression	0	10	2	0	0	Bedbound	Nonverbal	1	1	Mainstream_with_support	1	1	1	18	Respiratory_failure	1	48.7	13.9	8.7	0	0	7	13,890	69.6	42.1	35.5	19.4	69.8	85	1	1	1	1	0	0	0	98.2	16	1	0	0	0	0	0	0	0.24
HCG5-0000072	Male	White_non_Hispanic	Europe	Urban	Middle	Mandarin	Medicaid	XLP	IMM	538	308,240	XLR	7.97	0.5	3.655	9.597	5.943	5	6	17	1	1	0	0	null	Panel	2.25	1	1,500	1	Metabolic_specialist	14,518.82	6.66	Regression	21.2	56.4	33.5	58.1	96.1	0	0	1	2.8	3	0	null	0	68.7	0	0	0	1	0	0	1	0	0	-1.9	1.33	0	0	0	0	222.06	5.921	19.576	4.75	1.24	309.7	1.72	0.18	121.4	396	40.3	442.5	1,236.9	0	Supportive_only	null	null	null	null	null	4.92	0	Fully_covered	0	0	14.14	0	1,484	High_value	0.617	null	0	Not_applicable	0	null	0	0	Rapid	0	4	3	0	0	Wheelchair	AAC_device	0	0	Mainstream_with_support	1	3	0	null	null	0	39.6	7	2.4	1	45,031	7.8	13,394	60.4	55.4	75.8	74.2	31.6	56.7	0	0	1	1	1	1	1	34.4	8	1	0	0	0	0	0	3	0.46
HCG5-0000073	Female	Asian	Asia_Pacific	Rural	High	Spanish	Medicaid_CHIP	MPS_III_Sanfilippo	LSD	581	252,900	AR	8.01	0.7	2.244	10.774	8.53	8	9	19	3	0	0	0	null	Metabolic	43.63	0	900	1	Other	29,054.28	7.65	Profound_delay	50.4	51.7	54.3	50.5	52	0	0	1	5.59	6	0	null	0	105.3	0	0	1	1	0	0	0	0	1	-1.61	-2.91	0	0	0	1	189.85	12.198	35.15	4.37	3.7	47	1.6	0.294	198.7	327.6	27.5	2,292.4	2,125.3	0	Supportive_only	null	null	null	null	null	13.4	0	Fully_covered	0	0	36	0	579	Intermediate	0.618	null	0	Not_applicable	0	null	0	0	Stable	0	29	0	0	0	Bedbound	Nonverbal	1	0	Special_ed	0	5	1	18	Respiratory_failure	1	50.3	6.9	7.6	1	24,315	8.3	8,196	40.6	22	25.3	60.6	6.4	59.1	1	1	1	1	0	1	0	5.2	12	1	0	0	0	0	0	0	0
HCG5-0000074	Female	Hispanic	North_America	Urban	Middle	Arabic	Medicaid	Gaucher_type1	LSD	355	230,800	AR	4.93	0.05	2.427	8.294	5.866	2	4	17	1	0	0	0	null	WES	40.25	1	4,500	0	Metabolic_specialist	16,761.05	8.84	Delayed	62.8	66	34.5	61.8	87.3	0	0	0	1.19	0	0	null	1	64.4	0	0	0	0	1	0	1	1	0	-1.81	-0.52	0	0	0	0	345.31	16.346	9.501	2.24	2.19	39	2.81	0.12	20.7	764.3	55.6	1,177.9	4,567.9	1	Small_molecule	null	null	null	Eliglustat	8.49	14.85	112,530	Fully_covered	0	0	6.22	0	8,530	High_value	0.494	0.744	0	Responder	0	null	0	0	Slow_progression	4	16	1	1	0	Assisted	Limited_verbal	0	0	Special_ed	1	6	1	18	Respiratory_failure	0	51	10.4	0	1	37,583	5.9	4,244	68.4	85.7	95.9	39.7	100	34.6	0	0	1	1	0	1	1	29.9	13	0	1	0	0	0	0	2	0
HCG5-0000075	Male	White_non_Hispanic	North_America	Urban	Middle	Other	Medicaid_CHIP	Niemann_Pick_C	LSD	646	257,220	AR	7.71	0.55	0.038	9.392	9.354	2	21	9	1	1	0	0	null	WES	103.17	1	4,500	1	NBS_followup	5,668.64	6.73	Regression	62	62.5	68.7	53.9	107.7	1	0	0	3.74	3	0	null	0	79.8	0	0	0	1	1	0	1	1	0	-2.29	-0.07	0	0	1	0	280.5	39.255	6.771	1.33	4.64	46.4	1.02	0.243	486	702.7	83	355.2	251.6	1	Supportive_only	null	null	null	null	null	43.65	0	Fully_covered	0	0	30.7	0	8,244	Low_value	0.249	null	0	Not_applicable	0	null	0	0	Slow_progression	4	24	2	1	0	Wheelchair	AAC_device	0	0	Special_ed	1	0	0	null	null	0	48.2	12.9	14.3	1	12,530	7.6	22,101	42.4	20.3	43.7	36.2	21.9	10.7	1	0	1	1	0	1	1	24	27	1	1	0	0	0	1	1	2.72
HCG5-0000076	Female	Black_non_Hispanic	Asia_Pacific	Rural	Middle	English	Commercial	MMA	OA	27	251,000	AR	8.42	0.45	0.011	0.011	0	0	5	12	2	0	1	1	3.8	WES	3.03	0	4,500	1	NBS_followup	7,251.21	4.47	Profound_delay	57.9	50.6	42.5	52.5	43.9	0	0	0	0.55	4	0	null	1	59.8	1	1	0	1	1	0	0	0	0	-1.76	-3.71	1	1	0	0	56.17	11.755	28.272	1.13	0.58	20	3.32	0.108	20	556	36.9	262.2	5,686.6	0	Supportive_only	null	null	null	null	null	20.34	0	Prior_auth_required	0	0	4.64	0	3,189	Intermediate	0.192	null	0	Not_applicable	0	null	0	0	Moderate	1	7	4	0	1	Bedbound	Nonverbal	1	0	Special_ed	0	6	1	9.72	Cardiac	0	65.9	6.4	9.7	0	0	5.1	11,260	35.2	20.3	21.5	52	58	41.7	1	0	1	0	0	0	1	12.2	21	1	0	0	0	0	0	5	0
HCG5-0000077	Female	White_non_Hispanic	Asia_Pacific	Urban	High	Spanish	Medicaid	Myotonic_congenital	NM	590	160,900	AD	3.8	0.1	0.378	4.381	4.003	4	8	14	1	1	0	0	null	Metabolic	17.07	0	900	0	Metabolic_specialist	67,384.56	7.39	Delayed	100.8	69.6	67.5	83.6	70.3	0	0	1	2.26	4	0	null	0	63.2	0	0	0	0	0	0	1	0	0	-2.29	-3.79	0	0	0	0	10	8.737	19.027	5.69	2.33	47	2.05	0.182	104.7	668.7	87.8	578	5,032.5	0	Supportive_only	null	null	null	null	null	3.01	0	Fully_covered	0	0	36	0	72	High_value	0.402	null	0	Not_applicable	0	null	0	0	Slow_progression	1	29	1	0	0	Ambulatory	Verbal	0	0	Special_ed	1	4	0	null	null	0	29.8	11.1	6.1	0	0	5.2	753	64.3	47.9	54.1	78.7	32.2	21.7	0	1	1	1	0	0	0	65.4	10	1	0	0	0	0	0	0	0
HCG5-0000078	Female	Black_non_Hispanic	Sub_Saharan_Africa	Urban	Low	Spanish	Commercial	SMA_type1	NM	83,330	253,300	AR	8.77	0.9	0.005	0.005	0	0	2	36	5	0	1	1	1.8	Panel	4.01	0	1,500	1	NBS_followup	85,273.13	4.93	Profound_delay	67	46.2	83.3	92.5	33.8	0	1	1	3.83	3	0	null	1	38.7	0	0	0	0	0	1	1	1	0	-4.54	-1.73	0	0	0	0	204.57	43.9	11.517	0.64	5.41	21.1	1.6	0.251	222.6	304.1	54.2	1,098.5	1,029.5	1	Supportive_only	null	null	null	null	null	0.91	0	Denied	0	0	3.91	0	944	High_value	0.545	null	0	Not_applicable	0	null	0	0	Stable	4	6	2	1	1	Bedbound	Nonverbal	0	1	Special_ed	1	1	1	6.53	Respiratory_failure	1	61.7	12.2	14.2	1	22,136	7.8	29,203	62.1	27.3	11.6	43.9	33.7	55.2	0	0	0	0	0	0	0	148.9	21	1	1	0	1	0	0	5	3.98
HCG5-0000079	Male	White_non_Hispanic	Latin_America	Urban	High	English	Medicaid	Achondroplasia	SKEL	15	100,800	AD	5.97	0.04	0.059	0.709	0.65	2	8	1	0	0	0	0	null	Panel	5.9	0	1,500	1	Metabolic_specialist	113,538.88	4.35	Delayed	60	73.6	80.7	43.7	43.4	1	0	0	5.38	2	0	null	0	59.4	0	0	0	0	0	0	0	0	1	-0.86	-2.5	0	0	0	0	340.68	15.175	21.118	8.01	6.25	233.1	1.41	0.208	417.7	415.7	41.9	35.3	201.9	0	Supportive_only	null	null	null	null	null	1.88	0	Fully_covered	0	0	11.92	0	1,006	High_value	0.518	null	0	Not_applicable	0	null	0	0	Moderate	0	31	0	0	0	Assisted	Limited_verbal	0	0	Home_school_medical	1	0	0	null	null	0	29.7	9.2	8.6	1	40,011	5.9	5,103	60.1	55.8	27.6	27	34.7	53.7	0	0	0	1	0	0	0	32.4	8	0	0	1	0	0	0	1	2.82
HCG5-0000080	Male	White_non_Hispanic	Latin_America	Urban	Low	English	Commercial	Myotonic_congenital	NM	590	160,900	AD	5.54	0.1	2.197	8.676	6.48	5	8	6	1	0	0	0	null	Panel	7.42	1	1,500	0	Other	32,980.57	8.75	Delayed	47	74.4	39.4	125.3	60.6	0	0	0	2.47	4	0	null	0	91.2	0	0	1	0	0	0	0	0	0	0.14	-2.07	0	1	0	0	148.05	10.433	28.913	6.72	3.23	111.9	7.26	0.146	326	321.7	84.7	212.8	2,522.9	0	Supportive_only	null	null	null	null	null	5.74	0	Prior_auth_required	0	0	8.65	0	4,606	Intermediate	0.728	null	0	Not_applicable	0	null	0	0	Stable	1	17	0	0	0	Assisted	Limited_verbal	0	0	Special_ed	1	1	0	null	null	0	55.6	11.1	12.4	1	88,524	3.8	15,375	42.9	42.1	62.8	19.6	29.2	52.3	0	1	1	1	0	0	1	83.6	12	1	0	0	0	0	1	4	2.01
HCG5-0000081	Male	Asian	North_America	Urban	High	English	Commercial	OTC	UCD	664	311,250	XLR	9.83	0.52	0.01	0.209	0.199	0	6	15	3	0	0	0	null	WGS	10.34	0	8,500	1	Geneticist	11,027.91	8.76	Profound_delay	21.2	42.6	28.9	12.2	30.8	0	0	0	2.07	4	0	null	0	91.1	0	0	1	1	1	0	1	0	0	-3.2	-2.5	1	0	1	0	350.94	46.116	11.615	3.52	0.48	20	2.18	0.185	230.6	221.7	31.3	76.9	581.9	1	Small_molecule	null	null	null	Supportive_metabolic	1.02	1.7	1,154,285	Partial_coverage	0	0	25.55	1	1,250	Intermediate	0.364	0.688	0	Non_responder	0	null	0	0	Moderate	0	18	8	0	0	Bedbound	Nonverbal	1	0	Special_ed	1	0	0	null	null	0	21.1	17.8	10.1	0	0	4.4	9,610	21.2	18.1	22.6	31.9	59.5	51.2	0	0	1	1	0	0	0	28.8	7	1	0	1	0	0	0	3	2.41
HCG5-0000082	Male	Asian	Europe	Suburban	Low	Spanish	Medicaid_CHIP	SCID	IMM	183	300,400	XLR	10	0.92	0.006	0.006	0	0	2	8	2	0	1	1	2	Single_gene	4.33	0	800	1	NBS_followup	18,138.38	4.95	Profound_delay	40.4	26.9	87.5	42.3	14.5	0	0	1	1.67	0	0	null	0	66.3	0	0	1	0	1	0	0	0	0	-2.3	-0.6	0	0	0	0	66.58	33.546	16.037	10.19	5.91	24.6	2.13	0.32	1,406.7	380.4	18.6	192.4	369.4	1	SRT	null	null	null	null	0.88	5.06	463,144	Partial_coverage	0	0	22.63	1	629	Low_value	0.355	0.931	0	Responder	0	null	0	0	Stable	2	34	3	1	0	Bedbound	Nonverbal	1	0	Special_ed	0	2	0	null	null	0	45.8	11.7	11.9	1	18,860	4.9	1,652	41.8	12.6	23.2	31.2	90	38.3	0	0	0	1	0	0	0	45.8	25	0	0	0	1	1	0	3	4.9
HCG5-0000083	Male	Hispanic	North_America	Urban	Low	Mandarin	Commercial	MPS_I_Hurler	LSD	579	607,014	AR	7.91	0.8	0.019	0.019	0	0	3	23	6	0	1	1	7	Panel	0.47	0	1,500	1	NBS_followup	7,028.66	7.5	Regression	51.4	104.5	86.2	25.9	49.5	0	0	1	2.39	1	0	null	1	64.3	1	0	1	1	1	0	1	1	1	-0	-1.83	0	0	1	1	128.25	18.417	19.496	3.64	13.81	76.6	3.76	0.13	2,745.8	350.2	43.1	61.3	2,619.4	1	ASO	null	null	Custom_ASO	null	0.84	10.33	843,065	Prior_auth_required	0	0	2.62	0	8,689	Low_value	0.421	0.587	0	Non_responder	1	Cord	0	1	Stable	4	26	0	0	1	Wheelchair	AAC_device	1	0	Mainstream_with_support	1	1	1	5.68	Respiratory_failure	1	61.7	16.9	17.4	0	0	4.4	3,762	30.5	65	57.2	30.1	45.4	39.2	1	0	1	1	0	0	0	28	4	0	0	0	0	0	0	1	1.43
HCG5-0000084	Female	Other_Multi	Europe	Suburban	Low	Spanish	Uninsured	Gaucher_type1	LSD	355	230,800	AR	3.56	0.05	2.585	6.128	3.543	4	13	13	0	0	0	0	null	Panel	4.21	0	1,500	1	Other	6,789.26	5.16	Delayed	81.5	84.7	94.4	82.7	89.2	0	1	1	1.91	1	0	null	0	111.3	0	0	0	0	1	0	0	0	1	-2.73	1.38	0	0	1	0	72.2	16.181	8.039	6.26	1.56	20	1.34	0.207	246.8	329.9	45.8	33.6	6,754.4	1	ASO	null	null	Custom_ASO	null	6.27	5.37	87,299	Partial_coverage	0	0	4.94	0	2,626	Intermediate	0.212	0.57	0	Responder	0	null	0	0	Stable	1	15	0	0	0	Ambulatory	Verbal	1	0	Special_ed	1	0	0	null	null	0	39	11.6	14.5	1	27,757	6.4	875	59.3	64.9	66.3	90.3	17	54	0	1	1	1	0	0	1	75.7	5	1	1	0	0	0	0	11	1.05
HCG5-0000085	Male	Hispanic	Latin_America	Urban	Middle	English	Commercial	Fabry	LSD	324	301,500	XLR	4.68	0.04	3.429	5.847	2.418	1	12	8	0	1	0	0	null	WES	13.96	0	4,500	0	Metabolic_specialist	33,851.43	6.68	Delayed	59.9	85.5	28.4	88.2	53.1	0	0	0	2.19	3	1	Moderate	0	65.3	0	0	1	0	1	1	0	1	1	-1.33	-0.11	0	0	1	0	364.05	31.236	35.487	0.94	2.26	20	4.4	0.243	217	354.4	38.3	57.3	1,452.5	1	Small_molecule	null	null	null	Migalastat	7.29	13.55	390,231	Prior_auth_required	0	0	36	1	1,126	Intermediate	0.69	0.744	0	Responder	0	null	0	0	Stable	1	22	0	0	0	Assisted	Limited_verbal	0	0	Not_enrolled	1	2	0	null	null	0	44.3	18.5	17.3	1	28,586	4.8	2,768	57.7	24.9	72.1	28.3	30.3	80.1	0	0	0	1	0	0	0	103.3	12	1	0	0	0	0	0	6	0.39
HCG5-0000086	Male	Hispanic	North_America	Urban	Low	English	Medicaid_CHIP	Alexander	LD	58	203,450	AD	9.82	0.65	2.102	7.691	5.589	0	11	6	4	1	0	0	null	WES	22.59	0	4,500	1	Metabolic_specialist	43,700.31	5.67	Profound_delay	62	29.5	59.2	36.8	39.5	0	1	1	4.23	7	1	Mild	0	80.8	0	0	0	0	0	0	1	0	0	2	0.87	1	0	0	0	72.94	36.049	4.817	0.75	6.86	20	2.18	0.142	202	376.3	102.8	133.1	5,914.4	0	Supportive_only	null	null	null	null	null	5.11	0	Partial_coverage	0	0	7.31	0	562	High_value	0.375	null	0	Not_applicable	0	null	0	0	Slow_progression	3	48	2	0	0	Bedbound	Nonverbal	1	1	Not_enrolled	1	5	0	null	null	0	53.5	18.8	13.2	1	38,991	5.5	6,918	58.3	48.3	56.7	33.5	22.1	56.3	0	0	1	0	1	0	1	358.2	11	1	0	0	1	0	1	1	4.44
HCG5-0000087	Male	Hispanic	Europe	Urban	Low	English	Medicaid_CHIP	Leigh_syndrome	MITO	506	256,000	MT	9.99	0.68	0.457	2.19	1.733	9	20	13	1	1	0	0	null	Panel	5.46	1	1,500	1	Cardiologist	156,770.18	6.74	Profound_delay	10	41.7	16.8	53.6	73	0	0	0	3.84	8	0	null	0	99.3	0	0	0	1	1	1	0	1	0	-1.04	-3.1	1	0	0	0	1,422.04	26.79	10.825	3.71	7.03	59.3	0.97	0.331	117.6	569	63.5	466.5	3,512.7	0	Supportive_only	null	null	null	null	null	4.31	0	Partial_coverage	0	0	13.91	0	112	Cost_saving	0.466	null	0	Not_applicable	0	null	0	0	Moderate	0	14	0	0	0	Bedbound	Nonverbal	1	1	Mainstream	1	6	1	15.92	Respiratory_failure	0	17.3	12.7	2.4	0	0	5.1	6,428	56.7	28.6	50.9	90.9	42.3	58.4	0	0	1	1	0	1	1	29	13	1	0	0	1	0	1	3	4.24
HCG5-0000088	Male	White_non_Hispanic	North_America	Suburban	Middle	English	Commercial	Pompe_late_onset	LSD	365	232,300	AR	8.23	0.1	0.02	0.02	0	0	4	12	0	0	1	1	7.4	Panel	2.16	1	1,500	1	NBS_followup	24,964.64	5.78	Profound_delay	35.9	52.4	70.2	38.5	21.1	0	0	0	1.47	2	1	Moderate	1	54.9	1	0	0	1	1	0	1	0	0	-1.72	-1.41	0	0	1	0	109.73	24.744	24.307	6.29	8.91	156.3	1.62	0.379	384.1	272.5	41.2	100	458	1	ASO	null	null	Custom_ASO	null	0.14	65.29	211,754	Fully_covered	0	0	2.55	1	3,423	High_value	0.567	0.893	0	Partial	0	null	0	0	Stable	3	10	0	0	1	Bedbound	Nonverbal	0	1	Mainstream_with_support	1	6	0	null	null	0	52.5	9.4	7.6	0	0	4.2	3,072	67.1	8.8	66.4	35.8	35.3	81.6	1	0	1	1	0	0	1	43	4	0	0	0	0	0	0	2	0
HCG5-0000089	Male	White_non_Hispanic	North_America	Urban	Middle	Other	Medicaid	MERRF	MITO	551	545,000	MT	6.46	0.22	7.017	9.516	2.499	3	7	12	1	1	0	0	null	WGS	43.31	0	8,500	1	Other	7,926.36	6.22	Regression	38.6	23.6	39.6	19.1	105.1	0	0	0	1.7	0	0	null	1	24.8	1	0	0	0	1	0	0	1	0	-0.74	-0.18	0	1	0	0	402.7	12.859	4.708	9.59	8.27	50.6	1.15	0.256	1,125.4	192.5	44.5	94.4	1,038.9	0	Supportive_only	null	null	null	null	null	9.62	0	Partial_coverage	0	0	5.36	0	529	High_value	0.285	null	0	Not_applicable	0	null	0	0	Stable	11	36	0	0	0	Wheelchair	AAC_device	0	0	Mainstream_with_support	1	3	0	null	null	0	33.6	15.8	2.5	1	28,604	4.2	4,661	53.5	20.8	76.3	55.4	95.4	49.5	0	0	1	0	1	0	0	188.2	17	0	1	0	0	0	0	4	1
HCG5-0000090	Female	White_non_Hispanic	North_America	Urban	Middle	Other	Commercial	Pompe_late_onset	LSD	365	232,300	AR	6.09	0.1	0.008	0.008	0	0	3	15	0	0	1	1	2.9	Single_gene	3.66	0	800	1	NBS_followup	24,107.34	7.63	Regression	56.7	48.7	67.7	72.4	49.9	0	0	1	2.67	5	0	null	0	78.3	0	0	0	0	0	0	1	1	1	-0.87	0.32	0	0	1	0	111.15	13.571	26.688	3.89	0.84	1,149.7	2.34	0.256	20	512.3	47.3	378.1	5,320.2	1	SRT	null	null	null	null	0.08	11.28	134,616	Prior_auth_required	0	0	3.53	0	5,688	Low_value	0.47	0.901	0	Responder	0	null	0	0	Stable	6	31	4	0	0	Wheelchair	AAC_device	0	0	Special_ed	1	4	0	null	null	0	59.8	9.7	15.1	0	0	6.9	6,702	47.6	67.1	61	84.8	47.6	34.4	0	0	0	1	0	0	0	37.5	16	1	1	0	0	0	0	4	1.81
HCG5-0000091	Male	Black_non_Hispanic	North_America	Rural	High	Other	Medicaid	X_ALD	LD	43	300,100	XLR	6.65	0.55	0.006	0.006	0	0	3	7	1	0	1	1	2	WGS	1.57	0	8,500	1	NBS_followup	20,864.13	6.2	Regression	79.2	44.8	40	57.4	65.9	0	0	0	5.26	7	1	Moderate	1	44.6	1	0	0	0	1	0	0	0	0	-2.59	-1.44	0	0	0	0	690.64	19.017	14.458	5.46	2.16	20	1.38	0.083	199.6	560.2	64.6	335.4	1,030.4	1	Small_molecule	null	null	null	Supportive_metabolic	0.27	25.25	797,296	Partial_coverage	0	0	15.39	1	2,024	High_value	0.419	0.835	0	Partial	0	null	0	0	Rapid	2	19	1	0	0	Wheelchair	AAC_device	0	0	Special_ed	0	3	1	6.43	Cardiac	0	45.6	3.6	10.7	0	0	6.2	11,748	61.3	72.1	68.3	53	66.1	55.9	0	0	0	1	1	0	0	94.8	7	1	0	0	0	0	0	8	0.22
HCG5-0000092	Male	White_non_Hispanic	MENA	Suburban	Middle	Arabic	Commercial	ARG1	UCD	90	207,800	AR	3.49	0.25	2.88	5.229	2.349	7	18	7	4	1	0	0	null	Panel	10.07	1	1,500	1	NBS_followup	17,290.14	9	Delayed	72.1	66.9	67.9	68.2	107.9	0	0	1	2.84	1	0	null	0	84.3	0	0	0	0	0	0	0	0	0	-3.88	-1.2	1	0	0	0	664.82	9.347	40.152	8.41	5.83	103.2	1.29	0.097	1,460.2	436.6	46.4	1,591.5	4,101.5	1	Gene_therapy	null	Clinical_trial	null	null	5.74	26.17	50,196	Prior_auth_required	0	0	12.99	0	2,835	Intermediate	0.596	0.549	0	Partial	0	null	0	0	Stable	21	9	2	0	0	Ambulatory	Verbal	0	0	Home_school_medical	1	4	0	null	null	0	48.2	16.5	16.2	0	0	2	3,209	68.9	68.6	15.3	70	52.5	73.9	1	1	0	1	0	1	1	31.3	11	1	0	0	0	0	0	6	1.04
HCG5-0000093	Female	White_non_Hispanic	Europe	Urban	Low	Other	Medicaid	HCU_homocystinuria	OA	394	236,200	AR	5.45	0.08	0.012	0.012	0	0	3	16	2	0	1	1	4.2	MLPA	6.25	0	1,000	1	NBS_followup	36,657.55	3.9	Delayed	66.4	45.9	74.9	56.8	103.2	1	0	0	2.82	2	0	null	0	85.2	0	0	1	1	1	0	0	0	0	-1.09	-1.03	1	1	1	0	131.14	8.413	21.147	4.05	3.07	20	2.65	0.16	392.2	206.6	40.1	684.1	1,199.7	0	Supportive_only	null	null	null	null	null	6.67	0	Denied	1	0	20.11	0	428	Intermediate	0.422	null	0	Not_applicable	0	null	0	0	Moderate	0	20	4	1	0	Assisted	Limited_verbal	1	0	Mainstream	1	5	0	null	null	0	29.3	9	15.6	0	0	5	5,164	63.2	34	52.7	44.6	50.5	63.4	0	0	0	0	1	1	1	84.2	23	1	0	0	0	0	0	0	0
HCG5-0000094	Male	Black_non_Hispanic	Asia_Pacific	Rural	Low	English	Medicaid	MMA	OA	27	251,000	AR	6.12	0.45	0.003	0.003	0	0	3	4	0	1	1	1	1	Panel	1.12	0	1,500	0	NBS_followup	9,017.97	6.3	Regression	72.2	62.9	29.5	68	74.9	0	1	0	5.35	8	0	null	0	122.5	0	0	0	0	1	1	1	1	1	-0.91	-0.88	1	1	1	0	238.58	20.476	10.522	7.17	4.61	349.1	2.28	0.127	402	341.8	17.6	79.2	3,719.2	0	Supportive_only	null	null	null	null	null	31.52	0	Fully_covered	0	0	2.52	0	567	Low_value	0	null	0	Not_applicable	0	null	0	0	Moderate	5	12	2	0	0	Wheelchair	AAC_device	1	0	Special_ed	0	2	1	7.42	Cardiac	0	57.6	0.4	9.9	1	84,782	6.9	1,713	89.1	56.9	87.1	39.1	41.8	53	0	0	0	1	1	0	1	105.2	9	1	0	0	1	0	0	2	0.8
HCG5-0000095	Male	White_non_Hispanic	Asia_Pacific	Urban	High	English	Other_public	CMT_1A_1B	NM	101,081	118,220	AD	4.77	0.02	12	18	14.392	3	14	2	2	1	0	0	null	WES	28.23	1	4,500	1	Geneticist	30,262.04	8.67	Delayed	62.9	97	116.4	53.5	57	0	0	0	1.86	2	0	null	1	50.4	1	0	1	0	0	0	1	0	1	-2.16	3.06	0	0	0	0	648.04	54.082	15.006	1.82	2.95	245.5	4.6	0.212	35.8	421	27.2	117	2,776.9	0	Supportive_only	null	null	null	null	null	6.09	0	Partial_coverage	0	0	10.96	0	166	Intermediate	0.252	null	0	Not_applicable	0	null	0	0	Slow_progression	11	22	0	0	0	Assisted	Limited_verbal	0	0	Special_ed	1	1	0	null	null	0	44.8	12	18.9	1	29,776	6.5	1,775	70	60.5	51.7	27.3	53	18	0	0	1	1	0	1	1	229	29	0	0	0	0	0	0	3	0
HCG5-0000096	Female	White_non_Hispanic	North_America	Urban	Low	English	Commercial	MSUD	OA	511	248,600	AR	5.74	0.55	0.009	0.009	0	0	2	11	3	0	1	1	3.4	Single_gene	7.81	1	800	0	NBS_followup	48,358.97	6.79	Delayed	69.6	66.9	38.2	69.8	49.5	0	1	0	4.94	2	1	Moderate	0	50.2	0	0	1	0	0	0	0	0	0	0.17	0.1	1	1	1	0	245.75	3.436	15.499	1.19	2.24	99.1	4.48	0.053	568.2	214	54.3	556.2	1,410.5	0	Supportive_only	null	null	null	null	null	30.5	0	Prior_auth_required	0	0	6.81	0	3,433	High_value	0.15	null	0	Not_applicable	0	null	0	0	Slow_progression	10	21	4	0	0	Assisted	Limited_verbal	0	0	Special_ed	1	6	0	null	null	0	24.9	18.3	15.2	1	55,068	8.4	18,585	76.9	0	70	53	39.7	24.8	1	1	0	1	0	1	1	23.6	19	1	0	0	1	0	0	6	0.78
HCG5-0000097	Male	Hispanic	North_America	Urban	Middle	English	TRICARE	Fabry	LSD	324	301,500	XLR	4.11	0.04	4.577	18	15	1	7	7	7	1	0	0	null	Panel	25.41	0	1,500	1	Neurologist	96,544.95	4.89	Delayed	77.8	52.1	48.5	95.9	63.5	0	1	0	7.11	6	1	Mild	0	90	0	0	1	1	0	1	1	0	1	-0.07	-0.34	0	1	1	0	72.19	15.607	75.26	2.92	2.67	20	2.31	0.212	821.4	249.1	51	92.3	3,615.8	1	Small_molecule	null	null	null	Migalastat	18	2.57	950,071	Fully_covered	0	0	0.74	0	2,544	Intermediate	0.767	0.716	0	Responder	0	null	0	0	Stable	6	13	1	0	0	Assisted	Limited_verbal	0	0	Home_school_medical	1	4	0	null	null	0	37.5	8.7	10.4	1	30,713	5.5	27,698	40.2	64.3	68.2	68.5	55.5	53.6	0	0	0	1	1	0	0	93.5	8	1	0	0	0	0	1	6	1.88
HCG5-0000098	Female	Hispanic	Asia_Pacific	Urban	High	English	Uninsured	Pompe_infantile	LSD	365	232,300	AR	9.32	0.85	0.017	0.017	0	0	1	6	0	0	1	1	6.1	WES	0.41	1	4,500	1	NBS_followup	35,572.86	6.17	Profound_delay	19.1	22.6	47.9	78.6	87.5	1	0	0	6.58	1	1	Mild	0	125	0	0	0	1	0	0	1	0	1	-0.87	-2.41	0	0	0	0	194.43	28.368	13.147	8.33	1.21	97.8	3	0.154	311	339.2	15.8	171.3	208.5	1	Gene_therapy	null	Clinical_trial	null	null	1.3	7.12	719,739	Fully_covered	0	0	10.14	0	167	High_value	0.675	0.557	0	Responder	0	null	0	0	Stable	6	35	1	1	0	Bedbound	Nonverbal	0	0	Home_school_medical	1	3	0	null	null	0	58.1	11.7	13.5	0	0	6.3	7,372	29.2	40.9	41.4	88.2	29.5	46.8	0	1	0	1	0	0	0	46.7	18	1	0	0	0	0	0	1	0
HCG5-0000099	Female	White_non_Hispanic	North_America	Urban	High	English	Medicaid_CHIP	22q11_2_DiGeorge	SYN	567	188,400	AD	5.45	0.08	0.341	1.459	1.118	8	11	18	4	1	0	0	null	WES	3.19	0	4,500	0	Geneticist	68,789.64	7.49	Delayed	56.2	59.1	89	91.3	60	1	0	0	5.13	1	1	Mild	0	84.3	0	0	1	1	0	0	0	0	0	-2.13	-2.38	0	0	1	0	85.78	58.269	10.76	2.54	1.73	20	0.96	0.133	111.4	659.5	30.2	37.3	610.5	0	Supportive_only	null	null	null	null	null	12.74	0	Fully_covered	0	0	21.39	0	88	Cost_saving	0.033	null	0	Not_applicable	0	null	0	0	Moderate	5	4	2	1	0	Assisted	Limited_verbal	0	0	Mainstream	1	4	0	null	null	0	47.5	15.6	17.4	1	20,804	4.7	4,336	42.4	95.6	69.7	47.2	100	47.8	0	1	0	1	0	0	1	9	10	1	0	0	1	0	0	0	1.18

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.